https://www.caf-dcf.be/litterature/evans-syndrome-in-adults-an-observational-multicenter-study/ 2022-03-04T10:00:56+01:00 https://www.caf-dcf.be/fr/litterature/impact-of-early-low-dose-factor-viia-on-subsequent-transfusions-and-length-of-stay-in-cardiac-surgery/ 2022-03-04T09:59:17+01:00 https://www.caf-dcf.be/litterature/impact-of-early-low-dose-factor-viia-on-subsequent-transfusions-and-length-of-stay-in-cardiac-surgery/ 2022-03-04T09:58:52+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-and-safety-of-fibrinogen-concentrate-for-on‐demand-treatment-of-bleeding-and-surgical-prophylaxis-in-paediatric-patients-with-congenital-fibrinogen-deficiency/ 2022-03-04T09:55:22+01:00 https://www.caf-dcf.be/litterature/efficacy-and-safety-of-fibrinogen-concentrate-for-on‐demand-treatment-of-bleeding-and-surgical-prophylaxis-in-paediatric-patients-with-congenital-fibrinogen-deficiency/ 2022-03-04T09:54:33+01:00 https://www.caf-dcf.be/fr/litterature/hemophilia-gene-therapy-ushering-in-a-new-treatment-paradigm/ 2022-01-21T16:00:03+01:00 https://www.caf-dcf.be/litterature/hemophilia-gene-therapy-ushering-in-a-new-treatment-paradigm/ 2022-01-21T15:59:37+01:00 https://www.caf-dcf.be/fr/litterature/clinical-humanistic-and-economic-burden-of-severe-haemophilia-b-in-adults-receiving-factor-ix-prophylaxis-findings-from-the-chess-ii-real-world-burden-of-illness-study-in-europe/ 2022-01-21T15:57:51+01:00 https://www.caf-dcf.be/litterature/clinical-humanistic-and-economic-burden-of-severe-haemophilia-b-in-adults-receiving-factor-ix-prophylaxis-findings-from-the-chess-ii-real-world-burden-of-illness-study-in-europe/ 2022-01-21T15:57:30+01:00 https://www.caf-dcf.be/fr/litterature/infection-rates-and-tolerability-of-three-different-immunoglobulin-administration-modalities-in-patients-with-primary-immunodeficiency-diseases/ 2022-01-21T15:55:30+01:00 https://www.caf-dcf.be/litterature/infection-rates-and-tolerability-of-three-different-immunoglobulin-administration-modalities-in-patients-with-primary-immunodeficiency-diseases/ 2022-01-21T15:55:08+01:00 https://www.caf-dcf.be/fr/litterature/economic-evaluation-of-subcutaneous-versus-intravenous-immunoglobulin-therapy-in-chronic-inflammatory-demyelinating-polyneuropathy-a-real-life-study/ 2022-01-21T15:53:12+01:00 https://www.caf-dcf.be/litterature/economic-evaluation-of-subcutaneous-versus-intravenous-immunoglobulin-therapy-in-chronic-inflammatory-demyelinating-polyneuropathy-a-real-life-study/ 2022-01-21T15:52:51+01:00 https://www.caf-dcf.be/fr/litterature/3d-structures-of-iga-igm-and-components/ 2022-01-21T15:50:37+01:00 https://www.caf-dcf.be/litterature/3d-structures-of-iga-igm-and-components/ 2022-01-21T15:50:16+01:00 https://www.caf-dcf.be/fr/litterature/secondary-failure-immune-responses-to-approved-protein-therapeutics/ 2022-01-21T15:48:34+01:00 https://www.caf-dcf.be/litterature/secondary-failure-immune-responses-to-approved-protein-therapeutics/ 2022-01-21T15:48:11+01:00 https://www.caf-dcf.be/fr/litterature/effectiveness-and-safety-of-an-intravenous-immune-globulin-ivig-preparation-in-post-exposure-prophylaxis-pep-against-measles-in-infants/ 2022-01-21T15:42:57+01:00 https://www.caf-dcf.be/litterature/effectiveness-and-safety-of-an-intravenous-immune-globulin-ivig-preparation-in-post-exposure-prophylaxis-pep-against-measles-in-infants/ 2022-01-21T15:42:30+01:00 https://www.caf-dcf.be/fr/litterature/haematological-parameters-associated-with-postpartum-haemorrhage-after-vaginal-delivery-results-from-a-french-cohort-study/ 2022-01-21T15:40:19+01:00 https://www.caf-dcf.be/litterature/haematological-parameters-associated-with-postpartum-haemorrhage-after-vaginal-delivery-results-from-a-french-cohort-study/ 2022-01-21T15:39:39+01:00 https://www.caf-dcf.be/fr/litterature/postpartum-hemorrhage-in-patients-with-type-1-von-willebrand-disease-a-systematic-review/ 2022-01-21T15:37:44+01:00 https://www.caf-dcf.be/litterature/postpartum-hemorrhage-in-patients-with-type-1-von-willebrand-disease-a-systematic-review/ 2022-01-21T15:37:19+01:00 https://www.caf-dcf.be/fr/litterature/unusual-pattern-of-thrombotic-events-in-young-adult-non-critically-ill-patients-with-covid-19-may-result-from-an-undiagnosed-inherited-and-acquired-form-of-thrombophilia/ 2022-01-19T11:19:50+01:00 https://www.caf-dcf.be/litterature/unusual-pattern-of-thrombotic-events-in-young-adult-non-critically-ill-patients-with-covid-19-may-result-from-an-undiagnosed-inherited-and-acquired-form-of-thrombophilia/ 2022-01-19T11:19:22+01:00 https://www.caf-dcf.be/fr/litterature/frequency-and-clinical-correlates-of-anti-nerve-antibodies-in-a-large-population-of-cidp-patients-included-in-the-italian-database/ 2022-01-04T10:07:21+01:00 https://www.caf-dcf.be/litterature/effectiveness-and-safety-of-an-intravenous-immune-globulin-ivig-preparation-in-post-exposure-prophylaxis-pep-against-measles-in-infants/ 2021-12-21T15:41:01+01:00 https://www.caf-dcf.be/fr/litterature/persept-3-a-phase-3-clinical-trial-to-evaluate-the-haemostatic-efficacy-of-eptacog-beta-recombinant-human-fviia-in-perioperative-care-in-subjects-with-haemophilia-a-or-b-with-inhibitors/ 2021-11-09T15:35:33+01:00 https://www.caf-dcf.be/litterature/persept-3-a-phase-3-clinical-trial-to-evaluate-the-haemostatic-efficacy-of-eptacog-beta-recombinant-human-fviia-in-perioperative-care-in-subjects-with-haemophilia-a-or-b-with-inhibitors/ 2021-11-09T15:35:16+01:00 https://www.caf-dcf.be/fr/litterature/emicizumab-prophylaxis-in-infants-with-severe-haemophilia-a-without-inhibitors-illustrative-real-world-cases-to-support-shared-decision-making/ 2021-11-09T15:33:01+01:00 https://www.caf-dcf.be/litterature/emicizumab-prophylaxis-in-infants-with-severe-haemophilia-a-without-inhibitors-illustrative-real-world-cases-to-support-shared-decision-making/ 2021-11-09T15:32:42+01:00 https://www.caf-dcf.be/fr/litterature/prophylaxis-in-children-with-haemophilia-in-an-evolving-treatment-landscape/ 2021-11-09T15:30:58+01:00 https://www.caf-dcf.be/litterature/prophylaxis-in-children-with-haemophilia-in-an-evolving-treatment-landscape/ 2021-11-09T15:30:39+01:00 https://www.caf-dcf.be/fr/litterature/emerging-drugs-for-hemophilia-a-insights-into-phase-ii-and-iii-clinical-trials/ 2021-11-09T15:28:55+01:00 https://www.caf-dcf.be/litterature/emerging-drugs-for-hemophilia-a-insights-into-phase-ii-and-iii-clinical-trials/ 2021-11-09T15:28:37+01:00 https://www.caf-dcf.be/fr/litterature/the-role-of-plasma-exchange-in-the-treatment-of-refractory-autoimmune-neurological-diseases-a-narrative-review/ 2021-11-09T15:26:45+01:00 https://www.caf-dcf.be/litterature/the-role-of-plasma-exchange-in-the-treatment-of-refractory-autoimmune-neurological-diseases-a-narrative-review/ 2021-11-09T15:26:22+01:00 https://www.caf-dcf.be/fr/litterature/treatments-for-hbv-a-glimpse-into-the-future/ 2021-11-09T14:57:04+01:00 https://www.caf-dcf.be/litterature/treatments-for-hbv-a-glimpse-into-the-future/ 2021-11-09T14:56:38+01:00 https://www.caf-dcf.be/fr/litterature/factor-xiii-deficiency-a-review-of-clinical-presentation-and-management/ 2021-11-09T14:55:11+01:00 https://www.caf-dcf.be/litterature/factor-xiii-deficiency-a-review-of-clinical-presentation-and-management/ 2021-11-09T14:54:50+01:00 https://www.caf-dcf.be/fr/litterature/comments-on-u-shaped-relationship-between-preoperative-plasma-fibrinogen-levels-and-severe-peri-operative-bleeding-in-cardiac-surgery-a-report-from-the-perioperative-events-assessment-in-adult-cardi/ 2021-11-09T14:51:58+01:00 https://www.caf-dcf.be/litterature/comments-on-u-shaped-relationship-between-preoperative-plasma-fibrinogen-levels-and-severe-peri-operative-bleeding-in-cardiac-surgery-a-report-from-the-perioperative-events-assessment-in-adult-cardi/ 2021-11-09T14:51:33+01:00 https://www.caf-dcf.be/fr/litterature/low-immunogenicity-of-emicizumab-in-persons-with-haemophilia-a/ 2021-10-21T15:34:19+01:00 https://www.caf-dcf.be/litterature/low-immunogenicity-of-emicizumab-in-persons-with-haemophilia-a/ 2021-10-21T15:33:34+01:00 https://www.caf-dcf.be/fr/litterature/advances-in-the-management-of-haemophilia-emerging-treatments-and-their-mechanisms/ 2021-10-21T15:30:42+01:00 https://www.caf-dcf.be/litterature/advances-in-the-management-of-haemophilia-emerging-treatments-and-their-mechanisms/ 2021-10-21T15:30:06+01:00 https://www.caf-dcf.be/fr/litterature/recombinant-factor-viia-for-hemorrhagic-stroke-treatment-at-earliest-possible-time-fastest-protocol-for-a-phase-iii-double-blind-randomized-placebo-controlled-trial/ 2021-10-21T15:28:14+01:00 https://www.caf-dcf.be/litterature/recombinant-factor-viia-for-hemorrhagic-stroke-treatment-at-earliest-possible-time-fastest-protocol-for-a-phase-iii-double-blind-randomized-placebo-controlled-trial/ 2021-10-21T15:27:48+01:00 https://www.caf-dcf.be/fr/litterature/hemophilia-a-and-c-in-a-female-the-first-case-report-in-literature/ 2021-10-21T15:24:03+01:00 https://www.caf-dcf.be/litterature/hemophilia-a-and-c-in-a-female-the-first-case-report-in-literature/ 2021-10-21T15:23:27+01:00 https://www.caf-dcf.be/fr/litterature/recommended-primary-outcomes-for-clinical-trials-evaluating-hemostatic-agents-in-patients-with-intracranial-hemorrhage-a-consensus-statement/ 2021-10-21T15:21:24+01:00 https://www.caf-dcf.be/litterature/recommended-primary-outcomes-for-clinical-trials-evaluating-hemostatic-agents-in-patients-with-intracranial-hemorrhage-a-consensus-statement/ 2021-10-21T15:20:59+01:00 https://www.caf-dcf.be/fr/litterature/emicizumab-in-acquired-haemophilia-a-about-two-clinical-cases-and-literature-review/ 2021-10-21T15:17:10+01:00 https://www.caf-dcf.be/litterature/emicizumab-in-acquired-haemophilia-a-about-two-clinical-cases-and-literature-review/ 2021-10-21T15:16:46+01:00 https://www.caf-dcf.be/fr/litterature/the-eha-research-roadmap-blood-coagulation-and-hemostatic-disorders/ 2021-10-21T15:11:07+01:00 https://www.caf-dcf.be/litterature/the-eha-research-roadmap-blood-coagulation-and-hemostatic-disorders/ 2021-10-21T15:10:21+01:00 https://www.caf-dcf.be/litterature/randomized-trial-of-intravenous-immunoglobulin-maintenance-treatment-regimens-in-chronic-inflammatory-demyelinating-polyradiculoneuropathy/ 2021-10-21T13:52:53+01:00 https://www.caf-dcf.be/fr/litterature/a-randomized-phase-3-trial-evaluating-antithrombin-gamma-treatment-in-japanese-patients-with-early-onset-severe-preeclampsia-kouno-tori-study-study-protocol/ 2021-10-21T13:49:51+01:00 https://www.caf-dcf.be/litterature/a-randomized-phase-3-trial-evaluating-antithrombin-gamma-treatment-in-japanese-patients-with-early-onset-severe-preeclampsia-kouno-tori-study-study-protocol/ 2021-10-21T13:49:24+01:00 https://www.caf-dcf.be/fr/litterature/heparin-resistance-clinical-perspectives-and-management-strategies/ 2021-10-21T13:46:06+01:00 https://www.caf-dcf.be/litterature/heparin-resistance-clinical-perspectives-and-management-strategies/ 2021-10-21T13:45:34+01:00 https://www.caf-dcf.be/fr/litterature/first-line-administration-of-fibrinogen-concentrate-in-the-bleeding-trauma-patient-searching-for-effective-dosages-and-optimal-post-treatment-levels-limiting-massive-transfusion-further-resul/ 2021-10-21T12:59:52+01:00 https://www.caf-dcf.be/litterature/first-line-administration-of-fibrinogen-concentrate-in-the-bleeding-trauma-patient-searching-for-effective-dosages-and-optimal-post-treatment-levels-limiting-massive-transfusion-further-resul/ 2021-10-21T12:57:10+01:00 https://www.caf-dcf.be/fr/litterature/rare-defects-looking-at-the-dark-face-of-the-thrombosis/ 2021-10-21T12:52:17+01:00 https://www.caf-dcf.be/litterature/rare-defects-looking-at-the-dark-face-of-the-thrombosis/ 2021-10-21T12:50:43+01:00 https://www.caf-dcf.be/fr/litterature/recent-advances-in-the-treatment-of-hemophilia-a-review/ 2021-07-27T10:38:23+01:00 https://www.caf-dcf.be/litterature/recent-advances-in-the-treatment-of-hemophilia-a-review/ 2021-07-27T10:37:54+01:00 https://www.caf-dcf.be/fr/litterature/consensus-recommendations-for-intramuscular-covid-19-vaccination-in-patients-with-hemophilia/ 2021-07-27T10:35:56+01:00 https://www.caf-dcf.be/litterature/consensus-recommendations-for-intramuscular-covid-19-vaccination-in-patients-with-hemophilia/ 2021-07-27T10:31:32+01:00 https://www.caf-dcf.be/fr/litterature/fc-receptor-targeted-therapies-for-the-treatment-of-myasthenia-gravis/ 2021-07-27T10:29:50+01:00 https://www.caf-dcf.be/litterature/fc-receptor-targeted-therapies-for-the-treatment-of-myasthenia-gravis/ 2021-07-27T10:29:26+01:00 https://www.caf-dcf.be/fr/litterature/clinical-outcome-of-cidp-one-year-after-start-of-treatment-a-prospective-cohort-study/ 2021-07-27T10:27:54+01:00 https://www.caf-dcf.be/litterature/clinical-outcome-of-cidp-one-year-after-start-of-treatment-a-prospective-cohort-study/ 2021-07-27T10:27:29+01:00 https://www.caf-dcf.be/fr/litterature/administration-of-fibrinogen-concentrate-combined-with-prothrombin-complex-maintains-hemostasis-in-children-undergoing-congenital-heart-repair-a-long-term-propensity-score-matched-study/ 2021-07-27T10:26:02+01:00 https://www.caf-dcf.be/litterature/administration-of-fibrinogen-concentrate-combined-with-prothrombin-complex-maintains-hemostasis-in-children-undergoing-congenital-heart-repair-a-long-term-propensity-score-matched-study/ 2021-07-27T10:25:35+01:00 https://www.caf-dcf.be/fr/litterature/four-factor-prothrombin-complex-concentrate-an-indispensable-adjunct-in-coagulopathy-of-trauma-management-a-comparative-review-of-the-literature-over-2-decades/ 2021-07-27T10:23:54+01:00 https://www.caf-dcf.be/litterature/four-factor-prothrombin-complex-concentrate-an-indispensable-adjunct-in-coagulopathy-of-trauma-management-a-comparative-review-of-the-literature-over-2-decades/ 2021-07-27T10:23:25+01:00 https://www.caf-dcf.be/fr/litterature/fibrinogen-as-a-therapeutic-target-opportunities-and-challenges/ 2021-07-27T10:20:52+01:00 https://www.caf-dcf.be/litterature/fibrinogen-as-a-therapeutic-target-opportunities-and-challenges/ 2021-07-27T10:20:21+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-factor-adamts13-and-mortality-in-dialysis-patients/ 2021-07-15T15:29:43+01:00 https://www.caf-dcf.be/litterature/von-willebrand-factor-adamts13-and-mortality-in-dialysis-patients/ 2021-07-15T15:29:15+01:00 https://www.caf-dcf.be/fr/litterature/treatment-of-alpha-1-antitrypsin-deficiency-using-hepatic-specified-cells-derived-from-human-induced-pluripotent-stem-cells/ 2021-07-15T15:27:43+01:00 https://www.caf-dcf.be/litterature/treatment-of-alpha-1-antitrypsin-deficiency-using-hepatic-specified-cells-derived-from-human-induced-pluripotent-stem-cells/ 2021-07-15T15:27:18+01:00 https://www.caf-dcf.be/fr/litterature/haemophilia/ 2021-07-15T15:25:40+01:00 https://www.caf-dcf.be/litterature/haemophilia/ 2021-07-15T15:25:12+01:00 https://www.caf-dcf.be/fr/litterature/fibrinogen-in-traumatic-haemorrhage-2/ 2021-07-15T15:23:27+01:00 https://www.caf-dcf.be/litterature/fibrinogen-in-traumatic-haemorrhage-2/ 2021-07-15T15:23:01+01:00 https://www.caf-dcf.be/fr/litterature/there-may-not-be-a-definite-winner-but-fibrinogen-concentrate-is-clearly-a-factor-to-be-reckoned-with/ 2021-07-15T15:21:33+01:00 https://www.caf-dcf.be/litterature/there-may-not-be-a-definite-winner-but-fibrinogen-concentrate-is-clearly-a-factor-to-be-reckoned-with/ 2021-07-15T15:21:07+01:00 https://www.caf-dcf.be/fr/litterature/management-of-a-high-risk-surgery-with-emicizumab-and-factor-viii-in-a-child-with-a-severe-hemophilia-a-and-inhibitor/ 2021-07-15T15:19:17+01:00 https://www.caf-dcf.be/litterature/management-of-a-high-risk-surgery-with-emicizumab-and-factor-viii-in-a-child-with-a-severe-hemophilia-a-and-inhibitor/ 2021-07-15T15:18:48+01:00 https://www.caf-dcf.be/fr/litterature/pro-con-debate-fibrinogen-concentrate-or-cryoprecipitate-for-treatment-of-acquired-hypofibrinogenemia-in-cardiac-surgical-patients/ 2021-07-15T15:14:44+01:00 https://www.caf-dcf.be/litterature/pro-con-debate-fibrinogen-concentrate-or-cryoprecipitate-for-treatment-of-acquired-hypofibrinogenemia-in-cardiac-surgical-patients/ 2021-07-15T15:13:43+01:00 https://www.caf-dcf.be/fr/litterature/alpha-1-antitrypsin-deficiency-in-liver-explants-in-a-mexican-cohort-a-unique-cohort-to-assess-the-role-of-heterozygous-genotypes-in-liver-disease/ 2021-07-15T15:10:29+01:00 https://www.caf-dcf.be/litterature/alpha-1-antitrypsin-deficiency-in-liver-explants-in-a-mexican-cohort-a-unique-cohort-to-assess-the-role-of-heterozygous-genotypes-in-liver-disease/ 2021-07-15T15:10:04+01:00 https://www.caf-dcf.be/fr/litterature/novel-mutation-in-coagulation-factor-vii-carmel-mutation-identification-and-characterization/ 2021-07-15T15:08:00+01:00 https://www.caf-dcf.be/litterature/novel-mutation-in-coagulation-factor-vii-carmel-mutation-identification-and-characterization/ 2021-07-15T15:07:37+01:00 https://www.caf-dcf.be/fr/litterature/commercial-alpha-1-antitrypsin-preparations-markedly-differ-in-their-potential-to-inhibit-the-atp-induced-release-of-monocytic-interleukin-1-beta/ 2021-07-15T15:05:57+01:00 https://www.caf-dcf.be/litterature/commercial-alpha-1-antitrypsin-preparations-markedly-differ-in-their-potential-to-inhibit-the-atp-induced-release-of-monocytic-interleukin-1-beta/ 2021-07-15T15:05:29+01:00 https://www.caf-dcf.be/fr/litterature/european-academy-of-neurology-peripheral-nerve-society-guideline-on-diagnosis-and-treatment-of-chronic-inflammatory-demyelinating-polyradiculoneuropathy-report-of-a-joint-task-force-second/ 2021-07-15T15:03:25+01:00 https://www.caf-dcf.be/litterature/european-academy-of-neurology-peripheral-nerve-society-guideline-on-diagnosis-and-treatment-of-chronic-inflammatory-demyelinating-polyradiculoneuropathy-report-of-a-joint-task-force-second/ 2021-07-15T15:03:02+01:00 https://www.caf-dcf.be/fr/litterature/intravenous-immunoglobulin-treatment-for-patients-with-severe-covid-19-a-retrospective-multi-center-study/ 2021-07-15T15:01:03+01:00 https://www.caf-dcf.be/litterature/intravenous-immunoglobulin-treatment-for-patients-with-severe-covid-19-a-retrospective-multi-center-study/ 2021-07-15T15:00:40+01:00 https://www.caf-dcf.be/fr/litterature/immediate-high-dose-intravenous-immunoglobulins-followed-by-direct-thrombin-inhibitor-treatment-is-crucial-for-survival-in-sars-covid-19-adenoviral-vector-vaccine-induced-immune-thrombotic-thrombocyto/ 2021-07-15T14:59:14+01:00 https://www.caf-dcf.be/litterature/immediate-high-dose-intravenous-immunoglobulins-followed-by-direct-thrombin-inhibitor-treatment-is-crucial-for-survival-in-sars-covid-19-adenoviral-vector-vaccine-induced-immune-thrombotic-thrombocyto/ 2021-07-15T14:58:29+01:00 https://www.caf-dcf.be/fr/litterature/fibrinogen-in-traumatic-haemorrhage/ 2021-07-15T14:53:02+01:00 https://www.caf-dcf.be/litterature/fibrinogen-in-traumatic-haemorrhage/ 2021-07-15T14:52:33+01:00 https://www.caf-dcf.be/fr/litterature/fibrinogen-prophylaxis-for-reducing-perioperative-bleeding-in-patients-undergoing-radical-cystectomy-a-double-blind-placebo-controlled-randomized-trial/ 2021-07-15T14:49:40+01:00 https://www.caf-dcf.be/litterature/fibrinogen-prophylaxis-for-reducing-perioperative-bleeding-in-patients-undergoing-radical-cystectomy-a-double-blind-placebo-controlled-randomized-trial/ 2021-07-15T14:47:50+01:00 https://www.caf-dcf.be/fr/litterature/antithrombin-and-its-role-in-host-defense-and-inflammation/ 2021-06-11T14:15:42+01:00 https://www.caf-dcf.be/litterature/antithrombin-and-its-role-in-host-defense-and-inflammation/ 2021-06-11T14:15:19+01:00 https://www.caf-dcf.be/fr/litterature/safety-and-efficacy-of-bay-94-9027-an-extended-half-life-factor-viii-during-minor-surgical-procedures-in-patients-with-severe-haemophilia-a/ 2021-06-11T14:13:51+01:00 https://www.caf-dcf.be/litterature/safety-and-efficacy-of-bay-94-9027-an-extended-half-life-factor-viii-during-minor-surgical-procedures-in-patients-with-severe-haemophilia-a/ 2021-06-11T14:13:24+01:00 https://www.caf-dcf.be/fr/litterature/comparative-analysis-of-the-pivotal-studies-of-extended-half-life-recombinant-fviii-products-for-treatment-of-haemophilia-a/ 2021-06-11T14:11:58+01:00 https://www.caf-dcf.be/litterature/comparative-analysis-of-the-pivotal-studies-of-extended-half-life-recombinant-fviii-products-for-treatment-of-haemophilia-a/ 2021-06-11T14:11:35+01:00 https://www.caf-dcf.be/fr/litterature/increased-vwf-and-decreased-adamts-13-in-covid-19-creating-a-milieu-for-microthrombosis/ 2021-06-11T14:09:50+01:00 https://www.caf-dcf.be/litterature/increased-vwf-and-decreased-adamts-13-in-covid-19-creating-a-milieu-for-microthrombosis/ 2021-06-11T14:09:22+01:00 https://www.caf-dcf.be/fr/litterature/benefits-of-immunoglobulin-substitution-in-primary-and-secondary-immunodeficiencies-interim-analysis-of-a-prospective-long-term-non-interventional-study/ 2021-06-11T14:07:46+01:00 https://www.caf-dcf.be/litterature/benefits-of-immunoglobulin-substitution-in-primary-and-secondary-immunodeficiencies-interim-analysis-of-a-prospective-long-term-non-interventional-study/ 2021-06-11T14:07:00+01:00 https://www.caf-dcf.be/fr/litterature/viscoelastic-testing-to-assess-the-effects-of-rapid-fibrinogen-concentrate-administration-after-cardiopulmonary-bypass-insights-from-the-replace-study/ 2021-06-11T13:55:22+01:00 https://www.caf-dcf.be/litterature/viscoelastic-testing-to-assess-the-effects-of-rapid-fibrinogen-concentrate-administration-after-cardiopulmonary-bypass-insights-from-the-replace-study/ 2021-06-11T13:54:13+01:00 https://www.caf-dcf.be/fr/litterature/treatment-of-bleeding-in-patients-with-liver-disease/ 2021-06-11T13:52:18+01:00 https://www.caf-dcf.be/litterature/treatment-of-bleeding-in-patients-with-liver-disease/ 2021-06-11T13:51:08+01:00 https://www.caf-dcf.be/fr/litterature/therapeutic-application-of-fibrinogen-in-spine-surgery-a-review-article/ 2021-06-11T13:48:52+01:00 https://www.caf-dcf.be/litterature/therapeutic-application-of-fibrinogen-in-spine-surgery-a-review-article/ 2021-06-11T13:47:20+01:00 https://www.caf-dcf.be/fr/litterature/current-and-future-options-of-haemophilia-a-treatments/ 2021-06-11T12:11:52+01:00 https://www.caf-dcf.be/litterature/current-and-future-options-of-haemophilia-a-treatments/ 2021-06-11T12:11:26+01:00 https://www.caf-dcf.be/fr/litterature/translating-the-success-of-prophylaxis-in-haemophilia-to-von-willebrand-disease/ 2021-06-11T12:09:51+01:00 https://www.caf-dcf.be/litterature/translating-the-success-of-prophylaxis-in-haemophilia-to-von-willebrand-disease/ 2021-06-11T12:09:27+01:00 https://www.caf-dcf.be/fr/litterature/pharmacokinetic-study-of-kovaltry-in-thirty-five-pediatric-patients-aged/ 2021-06-11T12:05:17+01:00 https://www.caf-dcf.be/litterature/pharmacokinetic-study-of-kovaltry-in-thirty-five-pediatric-patients-aged/ 2021-06-11T12:04:50+01:00 https://www.caf-dcf.be/fr/litterature/recombinant-factor-viii-fc-for-the-treatment-of-haemophilia-a/ 2021-06-11T12:03:18+01:00 https://www.caf-dcf.be/litterature/recombinant-factor-viii-fc-for-the-treatment-of-haemophilia-a/ 2021-06-11T12:02:30+01:00 https://www.caf-dcf.be/fr/litterature/guillain-barre-syndrome-in-a-child-with-covid-19-infection/ 2021-06-11T12:00:47+01:00 https://www.caf-dcf.be/litterature/guillain-barre-syndrome-in-a-child-with-covid-19-infection/ 2021-06-11T12:00:24+01:00 https://www.caf-dcf.be/fr/litterature/immunoglobulin-for-myasthenia-gravis/ 2021-06-11T11:58:45+01:00 https://www.caf-dcf.be/litterature/immunoglobulin-for-myasthenia-gravis/ 2021-06-11T11:58:17+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-safety-and-strategies-for-recombinant-activated-factor-vii-in-cardiac-surgical-bleeding-a-narrative-review/ 2021-06-11T11:56:49+01:00 https://www.caf-dcf.be/litterature/efficacy-safety-and-strategies-for-recombinant-activated-factor-vii-in-cardiac-surgical-bleeding-a-narrative-review/ 2021-06-11T11:55:30+01:00 https://www.caf-dcf.be/fr/litterature/albumin-in-advanced-liver-diseases-the-good-and-bad-of-a-drug/ 2021-06-11T11:53:52+01:00 https://www.caf-dcf.be/litterature/albumin-in-advanced-liver-diseases-the-good-and-bad-of-a-drug/ 2021-06-11T11:53:29+01:00 https://www.caf-dcf.be/fr/litterature/a-randomized-trial-of-albumin-infusions-in-hospitalized-patients-with-cirrhosis/ 2021-06-11T11:50:20+01:00 https://www.caf-dcf.be/litterature/a-randomized-trial-of-albumin-infusions-in-hospitalized-patients-with-cirrhosis/ 2021-06-11T11:49:29+01:00 https://www.caf-dcf.be/fr/litterature/fundamental-knowledge-about-the-physical-and-chemical-properties-of-commercial-albumin-and-its-application-in-clinical-practice/ 2021-06-11T11:39:07+01:00 https://www.caf-dcf.be/litterature/fundamental-knowledge-about-the-physical-and-chemical-properties-of-commercial-albumin-and-its-application-in-clinical-practice/ 2021-06-11T11:38:43+01:00 https://www.caf-dcf.be/fr/litterature/management-of-covid‐19‐associated-coagulopathy-in-persons-with-haemophilia/ 2021-04-23T14:13:14+01:00 https://www.caf-dcf.be/litterature/management-of-covid‐19‐associated-coagulopathy-in-persons-with-haemophilia/ 2021-04-23T14:12:48+01:00 https://www.caf-dcf.be/fr/litterature/immune-responses-to-plasma-derived-versus-recombinant-fviii-products/ 2021-04-23T14:10:59+01:00 https://www.caf-dcf.be/litterature/immune-responses-to-plasma-derived-versus-recombinant-fviii-products/ 2021-04-23T14:10:39+01:00 https://www.caf-dcf.be/fr/litterature/novel-treatments-for-hemophilia-through-rebalancing-of-the-coagulation-cascade/ 2021-04-23T14:08:51+01:00 https://www.caf-dcf.be/litterature/novel-treatments-for-hemophilia-through-rebalancing-of-the-coagulation-cascade/ 2021-04-23T14:08:28+01:00 https://www.caf-dcf.be/fr/litterature/activated-factor-viii-mimicking-effect-by-emicizumab-on-thrombus-formation-in-type-2n-von-willebrand-disease-under-high-shear-flow-conditions/ 2021-04-23T14:07:01+01:00 https://www.caf-dcf.be/litterature/activated-factor-viii-mimicking-effect-by-emicizumab-on-thrombus-formation-in-type-2n-von-willebrand-disease-under-high-shear-flow-conditions/ 2021-04-23T14:06:41+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-disease-what-does-the-future-hold/ 2021-04-23T14:04:39+01:00 https://www.caf-dcf.be/litterature/von-willebrand-disease-what-does-the-future-hold/ 2021-04-23T14:04:12+01:00 https://www.caf-dcf.be/fr/litterature/biochemical-molecular-and-clinical-aspects-of-coagulation-factor-vii-and-its-role-in-hemostasis-and-thrombosis/ 2021-04-23T14:01:21+01:00 https://www.caf-dcf.be/litterature/biochemical-molecular-and-clinical-aspects-of-coagulation-factor-vii-and-its-role-in-hemostasis-and-thrombosis/ 2021-04-23T14:00:53+01:00 https://www.caf-dcf.be/fr/litterature/role-of-immunoglobulin-and-antibodies-in-disease-management/ 2021-04-23T13:58:51+01:00 https://www.caf-dcf.be/litterature/role-of-immunoglobulin-and-antibodies-in-disease-management/ 2021-04-23T13:58:27+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-and-safety-of-intravenous-immunoglobulins-for-the-treatment-of-viral-encephalitis-a-systematic-literature-review/ 2021-04-23T13:42:09+01:00 https://www.caf-dcf.be/litterature/efficacy-and-safety-of-intravenous-immunoglobulins-for-the-treatment-of-viral-encephalitis-a-systematic-literature-review/ 2021-04-23T13:41:36+01:00 https://www.caf-dcf.be/fr/litterature/characterization-of-antibodies-in-human-immunoglobulin-products-from-different-regions-worldwide/ 2021-04-23T13:35:44+01:00 https://www.caf-dcf.be/litterature/characterization-of-antibodies-in-human-immunoglobulin-products-from-different-regions-worldwide/ 2021-04-23T13:35:11+01:00 https://www.caf-dcf.be/fr/litterature/effects-of-adjunct-treatment-with-intravenous-immunoglobulins-on-the-course-of-severe-covid-19-results-from-a-retrospective-cohort-study/ 2021-04-23T13:31:58+01:00 https://www.caf-dcf.be/litterature/effects-of-adjunct-treatment-with-intravenous-immunoglobulins-on-the-course-of-severe-covid-19-results-from-a-retrospective-cohort-study/ 2021-04-23T13:31:31+01:00 https://www.caf-dcf.be/fr/litterature/review-of-indications-for-immunoglobulin-ig-use-narrowing-the-gap-between-supply-and-demand/ 2021-04-23T13:29:57+01:00 https://www.caf-dcf.be/litterature/review-of-indications-for-immunoglobulin-ig-use-narrowing-the-gap-between-supply-and-demand/ 2021-04-23T13:29:15+01:00 https://www.caf-dcf.be/fr/litterature/real-life-picture-of-the-use-of-intravenous-immunoglobulins-in-idiopathic-inflammatory-myopathies-results-of-a-multicentric-study/ 2021-04-23T13:27:33+01:00 https://www.caf-dcf.be/litterature/real-life-picture-of-the-use-of-intravenous-immunoglobulins-in-idiopathic-inflammatory-myopathies-results-of-a-multicentric-study/ 2021-04-23T13:27:12+01:00 https://www.caf-dcf.be/fr/litterature/role-of-fibrinogen-concentrates-for-treatment-of-critical-perioperative-hemorrhage/ 2021-04-23T13:25:46+01:00 https://www.caf-dcf.be/litterature/role-of-fibrinogen-concentrates-for-treatment-of-critical-perioperative-hemorrhage/ 2021-04-23T13:25:24+01:00 https://www.caf-dcf.be/fr/litterature/early-and-systematic-administration-of-fibrinogen-concentrate-in-postpartum-haemorrhage-following-vaginal-delivery-the-fidel-randomized-controlled-trial/ 2021-04-23T13:23:37+01:00 https://www.caf-dcf.be/litterature/early-and-systematic-administration-of-fibrinogen-concentrate-in-postpartum-haemorrhage-following-vaginal-delivery-the-fidel-randomized-controlled-trial/ 2021-04-23T13:23:16+01:00 https://www.caf-dcf.be/fr/litterature/association-between-intraoperative-rotational-thromboelastometry-or-conventional-coagulation-tests-and-bleeding-in-liver-transplantation-an-observational-exploratory-study/ 2021-04-23T13:21:29+01:00 https://www.caf-dcf.be/litterature/association-between-intraoperative-rotational-thromboelastometry-or-conventional-coagulation-tests-and-bleeding-in-liver-transplantation-an-observational-exploratory-study/ 2021-04-23T13:21:01+01:00 https://www.caf-dcf.be/fr/litterature/thrombin-generation-following-severe-trauma-mechanisms-modulators-and-implications-for-hemostasis-and-thrombosis/ 2021-04-23T13:19:20+01:00 https://www.caf-dcf.be/litterature/thrombin-generation-following-severe-trauma-mechanisms-modulators-and-implications-for-hemostasis-and-thrombosis/ 2021-04-23T13:18:56+01:00 https://www.caf-dcf.be/fr/litterature/transfusion-with-cryoprecipitate-for-very-low-fibrinogen-levels-does-not-affect-bleeding-or-survival-in-critically-ill-cirrhosis-patients-2/ 2021-04-23T13:17:23+01:00 https://www.caf-dcf.be/litterature/transfusion-with-cryoprecipitate-for-very-low-fibrinogen-levels-does-not-affect-bleeding-or-survival-in-critically-ill-cirrhosis-patients-2/ 2021-04-23T13:17:00+01:00 https://www.caf-dcf.be/fr/litterature/thrombotic-thrombocytopenic-purpura-pathophysiology-diagnosis-and-management/ 2021-04-23T13:14:29+01:00 https://www.caf-dcf.be/litterature/thrombotic-thrombocytopenic-purpura-pathophysiology-diagnosis-and-management/ 2021-04-23T13:13:06+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-disease-type-2n-an-update/ 2021-03-12T09:49:49+01:00 https://www.caf-dcf.be/litterature/von-willebrand-disease-type-2n-an-update/ 2021-03-12T09:49:21+01:00 https://www.caf-dcf.be/fr/litterature/the-availability-of-new-drugs-for-hemophilia-treatment/ 2021-03-12T09:47:31+01:00 https://www.caf-dcf.be/litterature/the-availability-of-new-drugs-for-hemophilia-treatment/ 2021-03-12T09:47:07+01:00 https://www.caf-dcf.be/fr/litterature/incidence-of-von-willebrand-disease-in-denmark-1995-2016-a-cohort-study/ 2021-03-12T09:45:10+01:00 https://www.caf-dcf.be/litterature/incidence-of-von-willebrand-disease-in-denmark-1995-2016-a-cohort-study/ 2021-03-12T09:44:43+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-and-safety-of-a-recombinant-von-willebrand-factor-treatment-in-patients-with-inherited-von-willebrand-disease-requiring-surgical-procedures/ 2021-03-12T09:42:52+01:00 https://www.caf-dcf.be/litterature/efficacy-and-safety-of-a-recombinant-von-willebrand-factor-treatment-in-patients-with-inherited-von-willebrand-disease-requiring-surgical-procedures/ 2021-03-12T09:42:07+01:00 https://www.caf-dcf.be/fr/litterature/key-questions-in-the-new-hemophilia-era-update-on-concomitant-use-of-fviii-and-emicizumab-in-hemophilia-a-patients-with-inhibitors/ 2021-03-12T09:40:06+01:00 https://www.caf-dcf.be/litterature/key-questions-in-the-new-hemophilia-era-update-on-concomitant-use-of-fviii-and-emicizumab-in-hemophilia-a-patients-with-inhibitors/ 2021-03-12T09:39:40+01:00 https://www.caf-dcf.be/fr/litterature/phase-ii-open-label-study-of-anakinra-in-intravenous-immunoglobulin-resistant-kawasaki-disease/ 2021-03-12T09:36:27+01:00 https://www.caf-dcf.be/litterature/phase-ii-open-label-study-of-anakinra-in-intravenous-immunoglobulin-resistant-kawasaki-disease/ 2021-03-12T09:35:56+01:00 https://www.caf-dcf.be/fr/litterature/transfusion-with-cryoprecipitate-for-very-low-fibrinogen-levels-does-not-affect-bleeding-or-survival-in-critically-ill-cirrhosis-patients/ 2021-03-12T09:34:00+01:00 https://www.caf-dcf.be/litterature/transfusion-with-cryoprecipitate-for-very-low-fibrinogen-levels-does-not-affect-bleeding-or-survival-in-critically-ill-cirrhosis-patients/ 2021-03-12T09:33:05+01:00 https://www.caf-dcf.be/fr/litterature/adamts13-activity-high-vwf-and-fviii-levels-in-the-pathogenesis-of-deep-vein-thrombosis/ 2021-03-02T16:08:39+01:00 https://www.caf-dcf.be/litterature/adamts13-activity-high-vwf-and-fviii-levels-in-the-pathogenesis-of-deep-vein-thrombosis/ 2021-03-02T16:08:10+01:00 https://www.caf-dcf.be/fr/litterature/real-world-evidence-on-kovaltry-81-8973-in-children-with-moderate-or-severe-hemophilia-a-in-europe-a-nested-cohort-analysis/ 2021-03-02T16:06:22+01:00 https://www.caf-dcf.be/litterature/real-world-evidence-on-kovaltry-81-8973-in-children-with-moderate-or-severe-hemophilia-a-in-europe-a-nested-cohort-analysis/ 2021-03-02T16:05:51+01:00 https://www.caf-dcf.be/fr/litterature/long-term-outcomes-with-emicizumab-prophylaxis-for-hemophilia-a-with-without-fviii-inhibitors-from-the-haven-1-4-studies/ 2021-03-02T16:04:30+01:00 https://www.caf-dcf.be/litterature/long-term-outcomes-with-emicizumab-prophylaxis-for-hemophilia-a-with-without-fviii-inhibitors-from-the-haven-1-4-studies/ 2021-03-02T16:04:00+01:00 https://www.caf-dcf.be/fr/litterature/rise-of-levels-of-von-willebrand-factor-and-factor-viii-with-age-role-of-genetic-and-acquired-risk-factors-2/ 2021-03-02T16:02:20+01:00 https://www.caf-dcf.be/litterature/rise-of-levels-of-von-willebrand-factor-and-factor-viii-with-age-role-of-genetic-and-acquired-risk-factors-2/ 2021-03-02T16:01:55+01:00 https://www.caf-dcf.be/fr/litterature/implications-of-a-change-of-paradigm-in-alpha1-antitrypsin-deficiency-augmentation-therapy-from-biochemical-to-clinical-efficacy/ 2021-03-02T16:00:15+01:00 https://www.caf-dcf.be/litterature/implications-of-a-change-of-paradigm-in-alpha1-antitrypsin-deficiency-augmentation-therapy-from-biochemical-to-clinical-efficacy/ 2021-03-02T15:59:48+01:00 https://www.caf-dcf.be/fr/litterature/antibodies-to-watch-in-2021/ 2021-03-02T15:58:07+01:00 https://www.caf-dcf.be/litterature/antibodies-to-watch-in-2021/ 2021-03-02T15:57:41+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-and-safety-of-antiviral-prophylaxis-during-pregnancy-to-prevent-mother-to-child-transmission-of-hepatitis-b-virus-a-systematic-review-and-meta-analysis/ 2021-03-02T15:46:48+01:00 https://www.caf-dcf.be/litterature/efficacy-and-safety-of-antiviral-prophylaxis-during-pregnancy-to-prevent-mother-to-child-transmission-of-hepatitis-b-virus-a-systematic-review-and-meta-analysis/ 2021-03-02T15:46:21+01:00 https://www.caf-dcf.be/fr/litterature/exploratory-in-vitro-evaluation-of-thrombin-generation-of-eptacog-beta-recombinant-human-fviia-and-emicizumab-in-congenital-haemophilia-a-plasma/ 2021-03-02T15:44:25+01:00 https://www.caf-dcf.be/litterature/exploratory-in-vitro-evaluation-of-thrombin-generation-of-eptacog-beta-recombinant-human-fviia-and-emicizumab-in-congenital-haemophilia-a-plasma/ 2021-03-02T15:43:53+01:00 https://www.caf-dcf.be/fr/litterature/clinical-phenotype-fibrinogen-supplementation-and-health-related-quality-of-life-in-patients-with-afibrinogenemia/ 2021-03-02T15:42:06+01:00 https://www.caf-dcf.be/litterature/clinical-phenotype-fibrinogen-supplementation-and-health-related-quality-of-life-in-patients-with-afibrinogenemia/ 2021-03-02T15:41:30+01:00 https://www.caf-dcf.be/fr/litterature/pharmacokinetics-surrogate-efficacy-and-safety-evaluations-of-a-new-human-plasma-derived-fibrinogen-concentrate-fib-grifols-in-adult-patients-with-congenital-afibrinogenemia/ 2021-03-02T15:39:45+01:00 https://www.caf-dcf.be/litterature/pharmacokinetics-surrogate-efficacy-and-safety-evaluations-of-a-new-human-plasma-derived-fibrinogen-concentrate-fib-grifols-in-adult-patients-with-congenital-afibrinogenemia/ 2021-03-02T15:38:09+01:00 https://www.caf-dcf.be/fr/litterature/variations-and-obstacles-in-the-use-of-coagulation-factor-concentrates-for-major-trauma-bleeding-across-europe-outcomes-from-a-european-expert-meeting/ 2021-03-02T15:35:54+01:00 https://www.caf-dcf.be/litterature/variations-and-obstacles-in-the-use-of-coagulation-factor-concentrates-for-major-trauma-bleeding-across-europe-outcomes-from-a-european-expert-meeting/ 2021-03-02T15:35:26+01:00 https://www.caf-dcf.be/fr/litterature/ash-isth-nhf-wfh-2021-guidelines-on-the-management-of-von-willebrand-disease/ 2021-03-02T15:32:09+01:00 https://www.caf-dcf.be/litterature/ash-isth-nhf-wfh-2021-guidelines-on-the-management-of-von-willebrand-disease/ 2021-03-02T15:31:39+01:00 https://www.caf-dcf.be/fr/litterature/alpha-1-antitrypsin-for-covid-19-treatment-dual-role-in-antiviral-infection-and-anti-inflammation/ 2021-03-02T15:30:05+01:00 https://www.caf-dcf.be/litterature/alpha-1-antitrypsin-for-covid-19-treatment-dual-role-in-antiviral-infection-and-anti-inflammation/ 2021-03-02T15:29:37+01:00 https://www.caf-dcf.be/fr/litterature/state-of-the-art-of-genetic-studies-in-hemophilia-carriers/ 2021-03-02T15:14:20+01:00 https://www.caf-dcf.be/litterature/state-of-the-art-of-genetic-studies-in-hemophilia-carriers/ 2021-03-02T15:13:54+01:00 https://www.caf-dcf.be/fr/litterature/general-concepts-on-hemophilia-a-and-on-women-carrying-the-disease/ 2021-03-02T15:11:23+01:00 https://www.caf-dcf.be/litterature/general-concepts-on-hemophilia-a-and-on-women-carrying-the-disease/ 2021-03-02T15:10:55+01:00 https://www.caf-dcf.be/fr/litterature/management-of-elective-procedures-in-low-von-willebrand-factor-patients-in-the-lovic-study/ 2021-03-02T15:08:57+01:00 https://www.caf-dcf.be/litterature/management-of-elective-procedures-in-low-von-willebrand-factor-patients-in-the-lovic-study/ 2021-03-02T15:08:24+01:00 https://www.caf-dcf.be/fr/litterature/monocytes-and-macrophages-in-alpha-i-antitrypsin-deficiency/ 2021-03-02T15:06:04+01:00 https://www.caf-dcf.be/litterature/monocytes-and-macrophages-in-alpha-i-antitrypsin-deficiency/ 2021-03-02T15:05:37+01:00 https://www.caf-dcf.be/fr/litterature/the-potential-role-of-emicizumab-prophylaxis-in-severe-von-willebrand-disease/ 2021-03-02T15:03:45+01:00 https://www.caf-dcf.be/litterature/the-potential-role-of-emicizumab-prophylaxis-in-severe-von-willebrand-disease/ 2021-03-02T15:02:59+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-and-safety-of-iqymune-r-in-patients-with-cidp-prism-study-results/ 2021-03-02T15:00:18+01:00 https://www.caf-dcf.be/litterature/efficacy-and-safety-of-iqymune-r-in-patients-with-cidp-prism-study-results/ 2021-03-02T14:59:42+01:00 https://www.caf-dcf.be/fr/litterature/evaluating-the-effects-of-intravenous-immunoglobulin-ivig-on-the-management-of-severe-covid-19-cases-a-randomized-controlled-trial/ 2021-03-02T14:57:46+01:00 https://www.caf-dcf.be/litterature/evaluating-the-effects-of-intravenous-immunoglobulin-ivig-on-the-management-of-severe-covid-19-cases-a-randomized-controlled-trial/ 2021-03-02T14:57:14+01:00 https://www.caf-dcf.be/fr/litterature/a-systematic-literature-review-of-the-effects-of-immunoglobulin-replacement-therapy-on-the-burden-of-secondary-immunodeficiency-diseases-associated-with-hematological-malignancies-and-stem-cell-transp/ 2021-03-02T14:54:35+01:00 https://www.caf-dcf.be/litterature/a-systematic-literature-review-of-the-effects-of-immunoglobulin-replacement-therapy-on-the-burden-of-secondary-immunodeficiency-diseases-associated-with-hematological-malignancies-and-stem-cell-transp/ 2021-03-02T14:53:46+01:00 https://www.caf-dcf.be/fr/litterature/a-comparison-of-prothrombin-complex-concentrate-and-recombinant-activated-factor-vii-for-the-management-of-bleeding-with-cardiac-surgery/ 2021-03-02T14:50:41+01:00 https://www.caf-dcf.be/litterature/a-comparison-of-prothrombin-complex-concentrate-and-recombinant-activated-factor-vii-for-the-management-of-bleeding-with-cardiac-surgery/ 2021-03-02T14:50:12+01:00 https://www.caf-dcf.be/fr/litterature/association-between-ionised-calcium-and-severity-of-postpartum-haemorrhage-a-retrospective-cohort-study/ 2021-03-02T14:04:44+01:00 https://www.caf-dcf.be/litterature/association-between-ionised-calcium-and-severity-of-postpartum-haemorrhage-a-retrospective-cohort-study/ 2021-03-02T14:04:13+01:00 https://www.caf-dcf.be/fr/litterature/prevention-of-postoperative-bleeding-after-complex-pediatric-cardiac-surgery-by-early-administration-of-fibrinogen-prothrombin-complex-and-platelets-a-prospective-observational-study/ 2021-03-02T14:01:50+01:00 https://www.caf-dcf.be/litterature/prevention-of-postoperative-bleeding-after-complex-pediatric-cardiac-surgery-by-early-administration-of-fibrinogen-prothrombin-complex-and-platelets-a-prospective-observational-study/ 2021-03-02T14:00:36+01:00 https://www.caf-dcf.be/fr/litterature/cost-effectiveness-of-emicizumab-vs-bypassing-agents-in-the-prevention-of-bleeding-episodes-in-haemophilia-a-patients-with-anti-fviii-inhibitors-in-france/ 2020-12-18T15:45:55+01:00 https://www.caf-dcf.be/litterature/cost-effectiveness-of-emicizumab-vs-bypassing-agents-in-the-prevention-of-bleeding-episodes-in-haemophilia-a-patients-with-anti-fviii-inhibitors-in-france/ 2020-12-18T15:45:37+01:00 https://www.caf-dcf.be/fr/litterature/a-new-drug-for-an-old-concept-aptamer-to-von-willebrand-factor-for-prevention-of-arterial-and-microvascular-thrombosis/ 2020-12-18T15:43:40+01:00 https://www.caf-dcf.be/litterature/a-new-drug-for-an-old-concept-aptamer-to-von-willebrand-factor-for-prevention-of-arterial-and-microvascular-thrombosis/ 2020-12-18T15:43:20+01:00 https://www.caf-dcf.be/fr/litterature/comparison-of-bypassing-agents-in-patients-on-emicizumab-using-global-hemostasis-assays/ 2020-12-18T15:41:35+01:00 https://www.caf-dcf.be/litterature/comparison-of-bypassing-agents-in-patients-on-emicizumab-using-global-hemostasis-assays/ 2020-12-18T15:41:20+01:00 https://www.caf-dcf.be/fr/litterature/the-german-hemophilia-registry-growing-with-its-tasks/ 2020-12-18T15:39:46+01:00 https://www.caf-dcf.be/litterature/the-german-hemophilia-registry-growing-with-its-tasks/ 2020-12-18T15:39:26+01:00 https://www.caf-dcf.be/fr/litterature/effectiveness-of-emicizumab-in-preventing-life-threatening-bleeding-complications-in-type-3-von-willebrand-disease-with-inhibitors-a-paediatric-report/ 2020-12-18T15:37:46+01:00 https://www.caf-dcf.be/litterature/effectiveness-of-emicizumab-in-preventing-life-threatening-bleeding-complications-in-type-3-von-willebrand-disease-with-inhibitors-a-paediatric-report/ 2020-12-18T15:37:31+01:00 https://www.caf-dcf.be/fr/litterature/real-world-data-of-immune-tolerance-induction-using-recombinant-factor-viii-fc-fusion-protein-in-patients-with-severe-haemophilia-a-with-inhibitors-at-high-risk-for-immune-tolerance-induction-failure/ 2020-12-18T15:36:14+01:00 https://www.caf-dcf.be/litterature/real-world-data-of-immune-tolerance-induction-using-recombinant-factor-viii-fc-fusion-protein-in-patients-with-severe-haemophilia-a-with-inhibitors-at-high-risk-for-immune-tolerance-induction-failure/ 2020-12-18T15:35:57+01:00 https://www.caf-dcf.be/fr/litterature/rise-of-levels-of-von-willebrand-factor-and-factor-viii-with-age-role-of-genetic-and-acquired-risk-factors/ 2020-12-18T15:34:05+01:00 https://www.caf-dcf.be/litterature/rise-of-levels-of-von-willebrand-factor-and-factor-viii-with-age-role-of-genetic-and-acquired-risk-factors/ 2020-12-18T15:33:46+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-factor/ 2020-12-18T15:32:03+01:00 https://www.caf-dcf.be/litterature/von-willebrand-factor/ 2020-12-18T15:31:42+01:00 https://www.caf-dcf.be/fr/litterature/hypothesis-alpha-1-antitrypsin-is-a-promising-treatment-option-for-covid-19/ 2020-12-18T15:30:21+01:00 https://www.caf-dcf.be/litterature/hypothesis-alpha-1-antitrypsin-is-a-promising-treatment-option-for-covid-19/ 2020-12-18T15:30:02+01:00 https://www.caf-dcf.be/fr/litterature/rurioctocog-alfa-pegol-pk-guided-prophylaxis-in-hemophilia-a-results-from-the-phase-3-propel-study/ 2020-12-18T15:28:10+01:00 https://www.caf-dcf.be/litterature/rurioctocog-alfa-pegol-pk-guided-prophylaxis-in-hemophilia-a-results-from-the-phase-3-propel-study/ 2020-12-18T15:27:50+01:00 https://www.caf-dcf.be/fr/litterature/type-i-interferon-antagonists-in-clinical-development-for-lupus/ 2020-12-18T15:25:59+01:00 https://www.caf-dcf.be/litterature/type-i-interferon-antagonists-in-clinical-development-for-lupus/ 2020-12-18T15:25:39+01:00 https://www.caf-dcf.be/fr/litterature/a-randomized-trial-of-convalescent-plasma-in-covid-19-severe-pneumonia/ 2020-12-18T15:24:03+01:00 https://www.caf-dcf.be/litterature/a-randomized-trial-of-convalescent-plasma-in-covid-19-severe-pneumonia/ 2020-12-18T15:23:42+01:00 https://www.caf-dcf.be/fr/litterature/durability-of-responses-after-sars-cov-2-mrna-1273-vaccination/ 2020-12-18T15:07:05+01:00 https://www.caf-dcf.be/litterature/durability-of-responses-after-sars-cov-2-mrna-1273-vaccination/ 2020-12-18T15:06:45+01:00 https://www.caf-dcf.be/fr/litterature/intravenous-immunoglobulin-immunotherapy-for-coronavirus-disease-19-covid-19/ 2020-12-18T15:04:45+01:00 https://www.caf-dcf.be/litterature/intravenous-immunoglobulin-immunotherapy-for-coronavirus-disease-19-covid-19/ 2020-12-18T15:04:23+01:00 https://www.caf-dcf.be/fr/litterature/individualized-intraoperative-dosing-of-fibrinogen-concentrate-for-the-prevention-of-bleeding-in-neonatal-and-infant-cardiac-surgery-using-cardiopulmonary-bypass-fibcon-a-phase-1b-2a-randomized-co/ 2020-12-18T15:00:08+01:00 https://www.caf-dcf.be/litterature/individualized-intraoperative-dosing-of-fibrinogen-concentrate-for-the-prevention-of-bleeding-in-neonatal-and-infant-cardiac-surgery-using-cardiopulmonary-bypass-fibcon-a-phase-1b-2a-randomized-co/ 2020-12-18T14:59:49+01:00 https://www.caf-dcf.be/fr/litterature/stability-of-reconstituted-fibrinogen-concentrate-in-hemostatic-function-and-concentration/ 2020-12-18T14:57:13+01:00 https://www.caf-dcf.be/litterature/stability-of-reconstituted-fibrinogen-concentrate-in-hemostatic-function-and-concentration/ 2020-12-18T14:56:49+01:00 https://www.caf-dcf.be/fr/litterature/antithrombin-deficiency-in-trauma-and-surgical-critical-care/ 2020-12-18T14:52:40+01:00 https://www.caf-dcf.be/litterature/antithrombin-deficiency-in-trauma-and-surgical-critical-care/ 2020-12-18T14:52:09+01:00 https://www.caf-dcf.be/fr/litterature/a-case-report-on-an-extremely-rare-disease-factor-xi-deficiency/ 2020-12-03T14:11:06+01:00 https://www.caf-dcf.be/litterature/a-case-report-on-an-extremely-rare-disease-factor-xi-deficiency/ 2020-12-03T14:10:48+01:00 https://www.caf-dcf.be/fr/litterature/global-immunoglobulin-supply-steaming-towards-the-iceberg/ 2020-12-03T14:09:07+01:00 https://www.caf-dcf.be/litterature/global-immunoglobulin-supply-steaming-towards-the-iceberg/ 2020-12-03T14:08:48+01:00 https://www.caf-dcf.be/fr/litterature/refractory-cidp-clinical-characteristics-antibodies-and-response-to-alternative-treatment/ 2020-12-03T14:06:54+01:00 https://www.caf-dcf.be/litterature/refractory-cidp-clinical-characteristics-antibodies-and-response-to-alternative-treatment/ 2020-12-03T14:06:13+01:00 https://www.caf-dcf.be/fr/litterature/severe-locked-in-like-guillain-barres-syndrome-dilemmas-in-diagnosis-and-treatment/ 2020-12-03T14:03:55+01:00 https://www.caf-dcf.be/litterature/severe-locked-in-like-guillain-barres-syndrome-dilemmas-in-diagnosis-and-treatment/ 2020-12-03T14:03:36+01:00 https://www.caf-dcf.be/fr/litterature/covid-19-and-multisystem-inflammatory-syndrome-in-children-and-adolescents/ 2020-12-03T14:01:26+01:00 https://www.caf-dcf.be/litterature/covid-19-and-multisystem-inflammatory-syndrome-in-children-and-adolescents/ 2020-12-03T14:01:04+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-of-prehospital-administration-of-fibrinogen-concentrate-in-trauma-patients-bleeding-or-presumed-to-bleed-fiintic-a-multicentre-double-blind-placebo-controlled-randomised-pilot-study-2/ 2020-12-03T13:59:07+01:00 https://www.caf-dcf.be/litterature/efficacy-of-prehospital-administration-of-fibrinogen-concentrate-in-trauma-patients-bleeding-or-presumed-to-bleed-fiintic-a-multicentre-double-blind-placebo-controlled-randomised-pilot-study-2/ 2020-12-03T13:58:45+01:00 https://www.caf-dcf.be/fr/litterature/role-of-von-willebrand-factor-after-injury-it-may-do-more-than-we-think/ 2020-12-03T13:56:20+01:00 https://www.caf-dcf.be/litterature/role-of-von-willebrand-factor-after-injury-it-may-do-more-than-we-think/ 2020-12-03T13:55:55+01:00 https://www.caf-dcf.be/fr/litterature/first-open-label-study-to-investigate-the-use-safety-and-tolerability-of-octaplaslg-in-patient-blood-management-in-two-cardiac-surgery-centres-in-france/ 2020-12-03T13:53:59+01:00 https://www.caf-dcf.be/litterature/first-open-label-study-to-investigate-the-use-safety-and-tolerability-of-octaplaslg-in-patient-blood-management-in-two-cardiac-surgery-centres-in-france/ 2020-12-03T13:53:29+01:00 https://www.caf-dcf.be/fr/litterature/pharmacokinetics-and-pharmacodynamics-of-emicizumab-in-persons-with-hemophilia-a-with-factor-viii-inhibitors-haven-1-study/ 2020-11-20T15:02:16+01:00 https://www.caf-dcf.be/litterature/pharmacokinetics-and-pharmacodynamics-of-emicizumab-in-persons-with-hemophilia-a-with-factor-viii-inhibitors-haven-1-study/ 2020-11-20T15:01:56+01:00 https://www.caf-dcf.be/fr/litterature/new-insights-into-ivig-mechanisms-and-alternatives-in-autoimmune-and-inflammatory-diseases-2/ 2020-11-20T14:53:54+01:00 https://www.caf-dcf.be/litterature/new-insights-into-ivig-mechanisms-and-alternatives-in-autoimmune-and-inflammatory-diseases-2/ 2020-11-20T14:53:37+01:00 https://www.caf-dcf.be/fr/litterature/dose-of-intravenous-immunoglobulins-in-chronic-inflammatory-demyelinating-polyneuropathy/ 2020-11-20T14:51:43+01:00 https://www.caf-dcf.be/litterature/dose-of-intravenous-immunoglobulins-in-chronic-inflammatory-demyelinating-polyneuropathy/ 2020-11-20T14:51:27+01:00 https://www.caf-dcf.be/fr/litterature/a-proposed-dosing-algorithm-for-the-individualized-dosing-of-human-immunoglobulin-in-chronic-inflammatory-neuropathies/ 2020-11-20T14:49:34+01:00 https://www.caf-dcf.be/litterature/a-proposed-dosing-algorithm-for-the-individualized-dosing-of-human-immunoglobulin-in-chronic-inflammatory-neuropathies/ 2020-11-20T14:49:15+01:00 https://www.caf-dcf.be/fr/litterature/clinical-and-economic-comparison-of-an-individualized-immunoglobulin-protocol-vs-standard-dosing-for-chronic-inflammatory-demyelinating-polyneuropathy/ 2020-11-20T14:47:20+01:00 https://www.caf-dcf.be/litterature/clinical-and-economic-comparison-of-an-individualized-immunoglobulin-protocol-vs-standard-dosing-for-chronic-inflammatory-demyelinating-polyneuropathy/ 2020-11-20T14:47:01+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-of-prehospital-administration-of-fibrinogen-concentrate-in-trauma-patients-bleeding-or-presumed-to-bleed-fiintic-a-multicentre-double-blind-placebo-controlled-randomised-pilot-study/ 2020-11-20T14:44:32+01:00 https://www.caf-dcf.be/litterature/efficacy-of-prehospital-administration-of-fibrinogen-concentrate-in-trauma-patients-bleeding-or-presumed-to-bleed-fiintic-a-multicentre-double-blind-placebo-controlled-randomised-pilot-study/ 2020-11-20T14:44:11+01:00 https://www.caf-dcf.be/fr/litterature/a-randomized-controlled-trial-of-antithrombin-supplementation-during-extracorporeal-membrane-oxygenation/ 2020-11-20T14:42:21+01:00 https://www.caf-dcf.be/litterature/a-randomized-controlled-trial-of-antithrombin-supplementation-during-extracorporeal-membrane-oxygenation/ 2020-11-20T14:42:01+01:00 https://www.caf-dcf.be/litterature/hemostatic-management-of-extracorporeal-circuits-including-cardiopulmonary-bypass-and-extracorporeal-membrane-oxygenation/ 2020-11-20T14:40:24+01:00 https://www.caf-dcf.be/fr/litterature/cryoprecipitate-transfusion-in-bleeding-patients/ 2020-11-20T14:39:31+01:00 https://www.caf-dcf.be/litterature/cryoprecipitate-transfusion-in-bleeding-patients/ 2020-11-20T14:39:12+01:00 https://www.caf-dcf.be/fr/litterature/hemostatic-management-of-extracorporeal-circuits-including-cardiopulmonary-bypass-and-extracorporeal-membrane-oxygenation/ 2020-11-20T14:36:55+01:00 https://www.caf-dcf.be/fr/litterature/from-routine-to-research-laboratory-strategies-for-the-diagnosis-of-congenital-fibrinogen-disorders/ 2020-11-20T14:34:15+01:00 https://www.caf-dcf.be/litterature/from-routine-to-research-laboratory-strategies-for-the-diagnosis-of-congenital-fibrinogen-disorders/ 2020-11-20T14:33:48+01:00 https://www.caf-dcf.be/fr/litterature/diagnostic-accuracy-of-viscoelastic-point-of-care-identification-of-hypofibrinogenaemia-in-cardiac-surgical-patients-a-systematic-review/ 2020-11-20T14:31:01+01:00 https://www.caf-dcf.be/litterature/diagnostic-accuracy-of-viscoelastic-point-of-care-identification-of-hypofibrinogenaemia-in-cardiac-surgical-patients-a-systematic-review/ 2020-11-20T14:29:52+01:00 https://www.caf-dcf.be/fr/litterature/kreuth-v-initiative-european-consensus-proposals-for-treatment-of-hemophilia-using-standard-products-extended-half-life-coagulation-factor-concentrates-and-non-replacement-therapies/ 2020-10-09T10:37:09+01:00 https://www.caf-dcf.be/litterature/kreuth-v-initiative-european-consensus-proposals-for-treatment-of-hemophilia-using-standard-products-extended-half-life-coagulation-factor-concentrates-and-non-replacement-therapies/ 2020-10-09T10:36:39+01:00 https://www.caf-dcf.be/fr/litterature/haemophilia-guidelines-for-all-a-new-ambition-of-the-world-federation-of-haemophilia-wfh/ 2020-10-09T10:33:40+01:00 https://www.caf-dcf.be/litterature/haemophilia-guidelines-for-all-a-new-ambition-of-the-world-federation-of-haemophilia-wfh/ 2020-10-09T10:32:49+01:00 https://www.caf-dcf.be/fr/litterature/use-of-recombinant-activated-factor-vii-for-uncontrolled-bleeding-in-a-haematology-oncology-paediatric-icu-cohort/ 2020-10-09T10:30:21+01:00 https://www.caf-dcf.be/litterature/use-of-recombinant-activated-factor-vii-for-uncontrolled-bleeding-in-a-haematology-oncology-paediatric-icu-cohort/ 2020-10-09T10:29:49+01:00 https://www.caf-dcf.be/litterature/management-of-previously-untreated-patients-with-severe-haemophilia-a-preferentially-treated-with-recombinant-factor-viii-products-two-french-centres-real-life-experience/ 2020-10-09T10:26:34+01:00 https://www.caf-dcf.be/litterature/bleeding-complications-during-pregnancy-and-delivery-in-haemophilia-carriers-and-their-neonates-in-western-france-an-observational-study/ 2020-10-09T10:26:07+01:00 https://www.caf-dcf.be/fr/litterature/bleeding-complications-during-pregnancy-and-delivery-in-haemophilia-carriers-and-their-neonates-in-western-france-an-observational-study/ 2020-10-09T10:24:24+01:00 https://www.caf-dcf.be/fr/litterature/management-of-previously-untreated-patients-with-severe-haemophilia-a-preferentially-treated-with-recombinant-factor-viii-products-two-french-centres-real-life-experience/ 2020-10-09T10:12:44+01:00 https://www.caf-dcf.be/fr/litterature/when-should-we-consider-that-cidp-patient-is-non-responder-to-ivig/ 2020-10-09T10:08:58+01:00 https://www.caf-dcf.be/litterature/when-should-we-consider-that-cidp-patient-is-non-responder-to-ivig/ 2020-10-09T10:08:31+01:00 https://www.caf-dcf.be/fr/litterature/open-label-phase-ii-study-with-anakinra-in-intravenous-immunoglobulin-resistant-kawasaki-disease/ 2020-10-09T09:54:15+01:00 https://www.caf-dcf.be/litterature/open-label-phase-ii-study-with-anakinra-in-intravenous-immunoglobulin-resistant-kawasaki-disease/ 2020-10-09T09:53:41+01:00 https://www.caf-dcf.be/fr/litterature/diagnosis-and-treatment-of-guillain-barre-syndrome-in-childhood-and-adolescence-an-evidence-and-consensus-based-guideline/ 2020-10-09T09:50:45+01:00 https://www.caf-dcf.be/litterature/diagnosis-and-treatment-of-guillain-barre-syndrome-in-childhood-and-adolescence-an-evidence-and-consensus-based-guideline/ 2020-10-09T09:50:20+01:00 https://www.caf-dcf.be/fr/litterature/randomised-trial-of-intravenous-immunoglobulin-maintenance-treatment-regimens-in-chronic-inflammatory-demyelinating-polradiculoneuropathy/ 2020-10-09T09:47:31+01:00 https://www.caf-dcf.be/litterature/randomised-trial-of-intravenous-immunoglobulin-maintenance-treatment-regimens-in-chronic-inflammatory-demyelinating-polradiculoneuropathy/ 2020-10-09T09:47:02+01:00 https://www.caf-dcf.be/fr/litterature/new-insights-into-ivig-mechanisms-and-alternatives-in-autoimmune-and-inflammatory-diseases/ 2020-10-09T09:31:00+01:00 https://www.caf-dcf.be/litterature/new-insights-into-ivig-mechanisms-and-alternatives-in-autoimmune-and-inflammatory-diseases/ 2020-10-09T09:30:08+01:00 https://www.caf-dcf.be/fr/litterature/guillain-barre-syndrome-spectrum-associated-with-covid-19-an-up-to-date-systematic-review-of-73-cases/ 2020-10-09T09:27:56+01:00 https://www.caf-dcf.be/litterature/guillain-barre-syndrome-spectrum-associated-with-covid-19-an-up-to-date-systematic-review-of-73-cases/ 2020-10-09T09:27:20+01:00 https://www.caf-dcf.be/fr/litterature/a-sars-cov-2-vaccine-candidate-would-likely-match-all-currently-circulating-variants/ 2020-10-09T09:25:35+01:00 https://www.caf-dcf.be/litterature/a-sars-cov-2-vaccine-candidate-would-likely-match-all-currently-circulating-variants/ 2020-10-09T09:25:05+01:00 https://www.caf-dcf.be/fr/litterature/covid-19-herd-immunity-where-are-we/ 2020-10-09T09:22:53+01:00 https://www.caf-dcf.be/litterature/covid-19-herd-immunity-where-are-we/ 2020-10-09T09:22:16+01:00 https://www.caf-dcf.be/fr/litterature/covid-19-coagulopathy-risk-of-thrombosis-and-the-rationale-for-anticoagulation/ 2020-10-09T09:20:27+01:00 https://www.caf-dcf.be/litterature/covid-19-coagulopathy-risk-of-thrombosis-and-the-rationale-for-anticoagulation/ 2020-10-09T09:19:28+01:00 https://www.caf-dcf.be/fr/litterature/the-debate-rotems-on-the-utility-of-point-of-care-testing-and-fibrinogen-concentrate-in-postpartum-haemorrhage/ 2020-10-09T09:15:41+01:00 https://www.caf-dcf.be/litterature/the-debate-rotems-on-the-utility-of-point-of-care-testing-and-fibrinogen-concentrate-in-postpartum-haemorrhage/ 2020-10-09T09:14:34+01:00 https://www.caf-dcf.be/litterature/von-willebrand-factor-and-factor-viii-clearance-in-perioperative-hemophilia-a-patients/ 2020-07-14T11:12:48+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-factor-and-factor-viii-clearance-in-perioperative-hemophilia-a-patients/ 2020-07-14T11:12:34+01:00 https://www.caf-dcf.be/litterature/antithrombotic-and-hemostatic-stewardship-evaluation-of-clinical-outcomes-and-adverse-events-of-recombinant-factor-viia-novoseven-utilization-at-a-large-academic-medical-center/ 2020-07-14T11:10:05+01:00 https://www.caf-dcf.be/fr/litterature/antithrombotic-and-hemostatic-stewardship-evaluation-of-clinical-outcomes-and-adverse-events-of-recombinant-factor-viia-novoseven-utilization-at-a-large-academic-medical-center/ 2020-07-14T11:09:48+01:00 https://www.caf-dcf.be/litterature/concomitant-use-of-rfviia-and-emicizumab-in-people-with-hemophilia-a-with-inhibitors-current-perspectives-and-emerging-clinical-evidence-2/ 2020-07-14T11:06:15+01:00 https://www.caf-dcf.be/fr/litterature/concomitant-use-of-rfviia-and-emicizumab-in-people-with-hemophilia-a-with-inhibitors-current-perspectives-and-emerging-clinical-evidence-2/ 2020-07-14T11:05:54+01:00 https://www.caf-dcf.be/litterature/von-willebrand-disease-diagnosis-and-treatment-treatment-of-women-and-genomic-approach-to-diagnosis/ 2020-07-14T11:03:58+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-disease-diagnosis-and-treatment-treatment-of-women-and-genomic-approach-to-diagnosis/ 2020-07-14T11:03:42+01:00 https://www.caf-dcf.be/litterature/the-acquired-von-willebrand-syndrome-focused-for-hematologists/ 2020-07-14T11:01:47+01:00 https://www.caf-dcf.be/fr/litterature/the-acquired-von-willebrand-syndrome-focused-for-hematologists/ 2020-07-14T11:01:32+01:00 https://www.caf-dcf.be/litterature/factor-viii-binding-affects-the-mechanical-unraveling-of-the-a2-domain-of-von-willebrand-factor/ 2020-07-14T11:00:04+01:00 https://www.caf-dcf.be/fr/litterature/factor-viii-binding-affects-the-mechanical-unraveling-of-the-a2-domain-of-von-willebrand-factor/ 2020-07-14T10:59:48+01:00 https://www.caf-dcf.be/litterature/management-of-thrombosis-in-a-pediatric-renal-transplant-patient-with-factor-vii-deficiency-a-dilemma-concerning-recombinant-factor-viia/ 2020-07-14T10:56:31+01:00 https://www.caf-dcf.be/fr/litterature/management-of-thrombosis-in-a-pediatric-renal-transplant-patient-with-factor-vii-deficiency-a-dilemma-concerning-recombinant-factor-viia/ 2020-07-14T10:56:13+01:00 https://www.caf-dcf.be/litterature/confronting-covid-19-issues-in-hemophilia-and-congenital-bleeding-disorders/ 2020-07-14T10:54:46+01:00 https://www.caf-dcf.be/fr/litterature/confronting-covid-19-issues-in-hemophilia-and-congenital-bleeding-disorders/ 2020-07-14T10:54:32+01:00 https://www.caf-dcf.be/litterature/recovery-of-severely-ill-covid-19-patients-by-intravenous-immunoglobulin-ivig-treatment-a-case-series/ 2020-07-14T10:52:36+01:00 https://www.caf-dcf.be/fr/litterature/recovery-of-severely-ill-covid-19-patients-by-intravenous-immunoglobulin-ivig-treatment-a-case-series/ 2020-07-14T10:52:22+01:00 https://www.caf-dcf.be/litterature/a-promising-antiviral-candidate-drug-for-the-covid-19-pandemic-a-mini-review-of-remdesivir/ 2020-07-14T10:50:14+01:00 https://www.caf-dcf.be/fr/litterature/a-promising-antiviral-candidate-drug-for-the-covid-19-pandemic-a-mini-review-of-remdesivir/ 2020-07-14T10:49:59+01:00 https://www.caf-dcf.be/litterature/autoinflammatory-and-autoimmune-conditions-at-the-crossroad-of-covid-19/ 2020-07-14T10:41:13+01:00 https://www.caf-dcf.be/fr/litterature/autoinflammatory-and-autoimmune-conditions-at-the-crossroad-of-covid-19/ 2020-07-14T10:40:48+01:00 https://www.caf-dcf.be/litterature/covid-19-convalescent-plasma-phase-2/ 2020-07-14T10:37:19+01:00 https://www.caf-dcf.be/fr/litterature/covid-19-convalescent-plasma-phase-2/ 2020-07-14T10:37:06+01:00 https://www.caf-dcf.be/litterature/practical-guidance-for-the-management-of-adults-with-immune-thrombocytopenia-during-the-covid-19-pandemic/ 2020-07-14T10:33:23+01:00 https://www.caf-dcf.be/fr/litterature/practical-guidance-for-the-management-of-adults-with-immune-thrombocytopenia-during-the-covid-19-pandemic/ 2020-07-14T10:33:07+01:00 https://www.caf-dcf.be/litterature/albumin-in-decompensated-cirrhosis-new-concepts-and-perspectives/ 2020-07-14T10:30:47+01:00 https://www.caf-dcf.be/fr/litterature/albumin-in-decompensated-cirrhosis-new-concepts-and-perspectives/ 2020-07-14T10:30:28+01:00 https://www.caf-dcf.be/litterature/coagulopathy-in-covid-19/ 2020-07-14T10:27:24+01:00 https://www.caf-dcf.be/fr/litterature/coagulopathy-in-covid-19/ 2020-07-14T10:26:58+01:00 https://www.caf-dcf.be/litterature/standardizing-care-to-manage-bleeding-disorders-in-adolescents-with-heavy-menses-a-joint-project-from-the-isth-pediatric-neonatal-and-womens-health-sscs/ 2020-07-14T10:18:55+01:00 https://www.caf-dcf.be/fr/litterature/standardizing-care-to-manage-bleeding-disorders-in-adolescents-with-heavy-menses-a-joint-project-from-the-isth-pediatric-neonatal-and-womens-health-sscs/ 2020-07-14T10:18:28+01:00 https://www.caf-dcf.be/litterature/hemophilia-a-disease-on-the-move/ 2020-06-30T15:51:06+01:00 https://www.caf-dcf.be/fr/litterature/hemophilia-a-disease-on-the-move/ 2020-06-30T15:50:56+01:00 https://www.caf-dcf.be/litterature/concomitant-use-of-rfviia-and-emicizumab-in-people-with-hemophilia-a-with-inhibitors-current-perspectives-and-emerging-clinical-evidence/ 2020-06-30T15:49:31+01:00 https://www.caf-dcf.be/fr/litterature/concomitant-use-of-rfviia-and-emicizumab-in-people-with-hemophilia-a-with-inhibitors-current-perspectives-and-emerging-clinical-evidence/ 2020-06-30T15:49:20+01:00 https://www.caf-dcf.be/fr/litterature/genetic-mosaicism-in-haemophilia-a-practical-review-to-help-evaluate-the-risk-of-transmitting-the-disease/ 2020-06-30T15:48:09+01:00 https://www.caf-dcf.be/litterature/genetic-mosaicism-in-haemophilia-a-practical-review-to-help-evaluate-the-risk-of-transmitting-the-disease/ 2020-06-30T15:47:45+01:00 https://www.caf-dcf.be/fr/litterature/annual-bleeding-rates-pitfalls-of-clinical-trial-outcomes-in-hemophilia-patients/ 2020-06-30T15:46:05+01:00 https://www.caf-dcf.be/litterature/annual-bleeding-rates-pitfalls-of-clinical-trial-outcomes-in-hemophilia-patients/ 2020-06-30T15:45:26+01:00 https://www.caf-dcf.be/litterature/six-molecular-patterns-leading-to-hemophilia-a-phenotype-in-18-females-from-poland/ 2020-06-30T15:43:26+01:00 https://www.caf-dcf.be/fr/litterature/six-molecular-patterns-leading-to-hemophilia-a-phenotype-in-18-females-from-poland/ 2020-06-30T15:43:12+01:00 https://www.caf-dcf.be/litterature/invasive-procedures-in-patients-with-haemophilia-review-of-low-dose-protocols-and-experience-with-extended-half-life-fviii-and-fix-concentrates-and-non-replacement-therapies/ 2020-06-30T15:39:58+01:00 https://www.caf-dcf.be/litterature/clinical-management-of-woman-with-bleeding-disorders-a-survey-among-european-haemophilia-treatment-centres/ 2020-06-30T15:39:10+01:00 https://www.caf-dcf.be/fr/litterature/clinical-management-of-woman-with-bleeding-disorders-a-survey-among-european-haemophilia-treatment-centres/ 2020-06-30T15:37:22+01:00 https://www.caf-dcf.be/fr/litterature/invasive-procedures-in-patients-with-haemophilia-review-of-low-dose-protocols-and-experience-with-extended-half-life-fviii-and-fix-concentrates-and-non-replacement-therapies/ 2020-06-30T15:36:10+01:00 https://www.caf-dcf.be/litterature/cytokine-storm-in-covid-19-pathogenesis-and-overview-of-anti-inflammatory-agents-used-in-treatment/ 2020-06-30T15:31:53+01:00 https://www.caf-dcf.be/fr/litterature/cytokine-storm-in-covid-19-pathogenesis-and-overview-of-anti-inflammatory-agents-used-in-treatment/ 2020-06-30T15:31:36+01:00 https://www.caf-dcf.be/litterature/kawasaki-disease-pathophysiology-and-insights-from-mouse-models/ 2020-06-30T15:30:11+01:00 https://www.caf-dcf.be/fr/litterature/kawasaki-disease-pathophysiology-and-insights-from-mouse-models/ 2020-06-30T15:29:54+01:00 https://www.caf-dcf.be/litterature/a-systematic-review-and-meta-regression-analysis-on-the-impact-of-increasing-igg-trough-level-on-infection-rates-in-primary-immunodeficiency-patients-on-intravenous-igg-therapy/ 2020-06-30T15:25:18+01:00 https://www.caf-dcf.be/fr/litterature/a-systematic-review-and-meta-regression-analysis-on-the-impact-of-increasing-igg-trough-level-on-infection-rates-in-primary-immunodeficiency-patients-on-intravenous-igg-therapy/ 2020-06-30T15:25:00+01:00 https://www.caf-dcf.be/litterature/relationship-between-post-ivig-igg-levels-and-clinical-outcomes-in-kawasaki-disease-patients-new-insight-into-the-mechanism-of-action-of-ivig/ 2020-06-30T15:23:24+01:00 https://www.caf-dcf.be/fr/litterature/relationship-between-post-ivig-igg-levels-and-clinical-outcomes-in-kawasaki-disease-patients-new-insight-into-the-mechanism-of-action-of-ivig/ 2020-06-30T15:22:59+01:00 https://www.caf-dcf.be/litterature/compendium-answering-150-questions-on-covid-19-and-sars-cov-2/ 2020-06-30T14:55:19+01:00 https://www.caf-dcf.be/fr/litterature/compendium-answering-150-questions-on-covid-19-and-sars-cov-2/ 2020-06-30T14:55:06+01:00 https://www.caf-dcf.be/litterature/delayed-specific-igm-antibody-responses-observed-among-covid-19-patients-with-severe-progression/ 2020-06-30T14:50:43+01:00 https://www.caf-dcf.be/fr/litterature/delayed-specific-igm-antibody-responses-observed-among-covid-19-patients-with-severe-progression/ 2020-06-30T14:50:27+01:00 https://www.caf-dcf.be/litterature/a-prospective-observational-study-of-acute-traumatic-coagulopathy-in-traumatic-bleeding-from-the-battlefield/ 2020-06-30T14:42:39+01:00 https://www.caf-dcf.be/fr/litterature/a-prospective-observational-study-of-acute-traumatic-coagulopathy-in-traumatic-bleeding-from-the-battlefield/ 2020-06-30T14:42:22+01:00 https://www.caf-dcf.be/litterature/empirical-transfusion-strategies-for-major-hemorrhage-in-trauma-patients-a-systematic-review/ 2020-06-30T14:34:18+01:00 https://www.caf-dcf.be/fr/litterature/empirical-transfusion-strategies-for-major-hemorrhage-in-trauma-patients-a-systematic-review/ 2020-06-30T14:33:57+01:00 https://www.caf-dcf.be/litterature/a-prospective-single-blind-randomized-phase-iii-study-to-evaluate-the-safety-and-efficacy-of-fibrin-sealant-grifols-as-an-adjunct-to-hemostasis-compared-with-manual-compression-in-vascular-surgery/ 2020-06-30T14:32:35+01:00 https://www.caf-dcf.be/fr/litterature/a-prospective-single-blind-randomized-phase-iii-study-to-evaluate-the-safety-and-efficacy-of-fibrin-sealant-grifols-as-an-adjunct-to-hemostasis-compared-with-manual-compression-in-vascular-surgery/ 2020-06-30T14:32:16+01:00 https://www.caf-dcf.be/litterature/current-perspective-on-fibrinogen-concentrate-in-critical-bleeding/ 2020-06-30T14:29:14+01:00 https://www.caf-dcf.be/fr/litterature/current-perspective-on-fibrinogen-concentrate-in-critical-bleeding/ 2020-06-30T14:28:59+01:00 https://www.caf-dcf.be/litterature/anticoagulant-treatment-and-bleeding-complications-in-patients-with-left-ventricular-assist-devices/ 2020-06-30T14:26:35+01:00 https://www.caf-dcf.be/fr/litterature/anticoagulant-treatment-and-bleeding-complications-in-patients-with-left-ventricular-assist-devices/ 2020-06-30T14:26:18+01:00 https://www.caf-dcf.be/litterature/which-is-the-preferred-blood-product-for-fibrinogen-replacement-in-the-bleeding-patient-with-acquired-hypofibrinogenemia-cryoprecipitate-or-fibrinogen-concentrate/ 2020-06-30T14:24:36+01:00 https://www.caf-dcf.be/fr/litterature/which-is-the-preferred-blood-product-for-fibrinogen-replacement-in-the-bleeding-patient-with-acquired-hypofibrinogenemia-cryoprecipitate-or-fibrinogen-concentrate/ 2020-06-30T14:24:09+01:00 https://www.caf-dcf.be/litterature/management-of-von-willebrand-disease-with-a-factor-viii-poor-von-willebrand-factor-concentrate-results-from-a-prospective-observational-post-marketing-study/ 2020-06-30T10:44:34+01:00 https://www.caf-dcf.be/fr/litterature/management-of-von-willebrand-disease-with-a-factor-viii-poor-von-willebrand-factor-concentrate-results-from-a-prospective-observational-post-marketing-study/ 2020-06-30T10:44:20+01:00 https://www.caf-dcf.be/litterature/new-developments-in-von-willebrand-disease/ 2020-06-30T10:41:51+01:00 https://www.caf-dcf.be/fr/litterature/new-developments-in-von-willebrand-disease/ 2020-06-30T10:41:38+01:00 https://www.caf-dcf.be/litterature/traumatic-injury-results-in-prolonged-circulation-of-ultralarge-von-willebrand-factor-and-a-reduction-in-adamts13-activity/ 2020-06-30T10:39:33+01:00 https://www.caf-dcf.be/fr/litterature/traumatic-injury-results-in-prolonged-circulation-of-ultralarge-von-willebrand-factor-and-a-reduction-in-adamts13-activity/ 2020-06-30T10:39:21+01:00 https://www.caf-dcf.be/fr/litterature/higher-rates-of-bleeding-and-use-of-treatment-products-among-young-boys-compared-to-girls-with-von-willebrand-disease/ 2020-06-30T10:37:47+01:00 https://www.caf-dcf.be/litterature/higher-rates-of-bleeding-and-use-of-treatment-products-among-young-boys-compared-to-girls-with-von-willebrand-disease/ 2020-06-30T10:37:29+01:00 https://www.caf-dcf.be/litterature/prevalence-and-incidence-of-non-neutralizing-antibodies-in-congenital-hemophilia-a-a-systematic-review-and-meta-analysis/ 2020-06-30T10:34:26+01:00 https://www.caf-dcf.be/fr/litterature/prevalence-and-incidence-of-non-neutralizing-antibodies-in-congenital-hemophilia-a-a-systematic-review-and-meta-analysis/ 2020-06-30T10:34:12+01:00 https://www.caf-dcf.be/litterature/long-term-safety-and-efficacy-of-rituximab-in-248-adults-with-immune-thrombocytopenia-results-at-5-years-from-the-french-prospective-registry-itp-ritux/ 2020-06-30T10:31:01+01:00 https://www.caf-dcf.be/fr/litterature/long-term-safety-and-efficacy-of-rituximab-in-248-adults-with-immune-thrombocytopenia-results-at-5-years-from-the-french-prospective-registry-itp-ritux/ 2020-06-30T10:30:30+01:00 https://www.caf-dcf.be/litterature/patient-experience-with-subcutaneous-immunoglobulin-20-ig20gly-for-primary-immunodeficiency-diseases-a-prespecified-post-hoc-analysis-of-combined-data-from-2-pivotal-trials/ 2020-06-30T10:28:25+01:00 https://www.caf-dcf.be/fr/litterature/patient-experience-with-subcutaneous-immunoglobulin-20-ig20gly-for-primary-immunodeficiency-diseases-a-prespecified-post-hoc-analysis-of-combined-data-from-2-pivotal-trials/ 2020-06-30T10:28:06+01:00 https://www.caf-dcf.be/litterature/response-to-eculizumab-in-patients-with-myasthenia-gravis-recently-treated-with-chronic-ivig-a-subgroup-analysis-of-regain-and-its-open-label-extension-study/ 2020-06-30T10:26:40+01:00 https://www.caf-dcf.be/fr/litterature/response-to-eculizumab-in-patients-with-myasthenia-gravis-recently-treated-with-chronic-ivig-a-subgroup-analysis-of-regain-and-its-open-label-extension-study/ 2020-06-30T10:26:24+01:00 https://www.caf-dcf.be/litterature/covid-19-in-patients-with-myasthenia-gravis/ 2020-06-30T10:24:33+01:00 https://www.caf-dcf.be/fr/litterature/covid-19-in-patients-with-myasthenia-gravis/ 2020-06-30T10:24:20+01:00 https://www.caf-dcf.be/litterature/immune-thrombocytopenia-in-adults-modern-approaches-to-diagnosis-and-treatment/ 2020-06-30T10:22:51+01:00 https://www.caf-dcf.be/fr/litterature/immune-thrombocytopenia-in-adults-modern-approaches-to-diagnosis-and-treatment/ 2020-06-30T10:22:38+01:00 https://www.caf-dcf.be/litterature/virological-assessment-of-hospitalized-patients-with-covid-2019/ 2020-06-30T10:18:52+01:00 https://www.caf-dcf.be/fr/litterature/virological-assessment-of-hospitalized-patients-with-covid-2019/ 2020-06-30T10:18:38+01:00 https://www.caf-dcf.be/litterature/comparison-of-clinical-characteristics-of-patients-with-asymptomatic-vs-symptomatic-coronavirus-disease-2019-in-wuhan-china/ 2020-06-30T10:14:49+01:00 https://www.caf-dcf.be/fr/litterature/comparison-of-clinical-characteristics-of-patients-with-asymptomatic-vs-symptomatic-coronavirus-disease-2019-in-wuhan-china/ 2020-06-30T10:14:27+01:00 https://www.caf-dcf.be/litterature/rational-use-of-tocilizumab-in-the-treatment-of-novel-coronavirus-pneumonia/ 2020-06-30T10:11:07+01:00 https://www.caf-dcf.be/fr/litterature/rational-use-of-tocilizumab-in-the-treatment-of-novel-coronavirus-pneumonia/ 2020-06-30T10:10:50+01:00 https://www.caf-dcf.be/litterature/treatment-of-covid-19-patients-with-convalescent-plasma/ 2020-06-30T10:04:10+01:00 https://www.caf-dcf.be/fr/litterature/treatment-of-covid-19-patients-with-convalescent-plasma/ 2020-06-30T10:03:52+01:00 https://www.caf-dcf.be/litterature/impact-of-immune-enhancement-on-covid-19-polyclonal-hyperimmune-globulin-therapy-and-vaccine-development/ 2020-06-30T10:01:43+01:00 https://www.caf-dcf.be/fr/litterature/impact-of-immune-enhancement-on-covid-19-polyclonal-hyperimmune-globulin-therapy-and-vaccine-development/ 2020-06-30T10:01:24+01:00 https://www.caf-dcf.be/litterature/effect-of-convalescent-plasma-therapy-on-time-to-clinical-improvement-in-patients-with-severe-and-life-threatening-covid-19-a-randomized-clinical-trial/ 2020-06-30T09:59:34+01:00 https://www.caf-dcf.be/fr/litterature/effect-of-convalescent-plasma-therapy-on-time-to-clinical-improvement-in-patients-with-severe-and-life-threatening-covid-19-a-randomized-clinical-trial/ 2020-06-30T09:59:20+01:00 https://www.caf-dcf.be/litterature/covid-19-convalescent-plasma-now-is-the-time-for-better-science/ 2020-06-30T09:56:24+01:00 https://www.caf-dcf.be/fr/litterature/covid-19-convalescent-plasma-now-is-the-time-for-better-science/ 2020-06-30T09:56:10+01:00 https://www.caf-dcf.be/litterature/a-randomized-trial-of-convalescent-plasma-for-covid-19-potentially-hopeful-signals/ 2020-06-30T09:54:30+01:00 https://www.caf-dcf.be/fr/litterature/a-randomized-trial-of-convalescent-plasma-for-covid-19-potentially-hopeful-signals/ 2020-06-30T09:54:16+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-and-safety-of-fibrinogen-concentrate-for-congenital-fibrinogen-deficiency-in-children/ 2020-06-30T09:52:44+01:00 https://www.caf-dcf.be/litterature/efficacy-and-safety-of-fibrinogen-concentrate-for-congenital-fibrinogen-deficiency-in-children/ 2020-06-30T09:52:28+01:00 https://www.caf-dcf.be/litterature/pathophysiological-response-to-trauma-induced-coagulopathy-a-comprehensive-review/ 2020-06-30T09:46:38+01:00 https://www.caf-dcf.be/fr/litterature/pathophysiological-response-to-trauma-induced-coagulopathy-a-comprehensive-review/ 2020-06-30T09:46:03+01:00 https://www.caf-dcf.be/litterature/evolution-of-viscoelastic-coagulation-testing/ 2020-06-30T09:43:48+01:00 https://www.caf-dcf.be/fr/litterature/evolution-of-viscoelastic-coagulation-testing/ 2020-06-30T09:42:23+01:00 https://www.caf-dcf.be/litterature/bleeding-symptoms-in-patients-diagnosed-as-type-3-von-willebrand-disease-results-from-3winters-ips-an-international-and-collaborative-cross-sectional-study/ 2020-06-05T13:51:00+01:00 https://www.caf-dcf.be/fr/litterature/bleeding-symptoms-in-patients-diagnosed-as-type-3-von-willebrand-disease-results-from-3winters-ips-an-international-and-collaborative-cross-sectional-study/ 2020-06-05T13:50:48+01:00 https://www.caf-dcf.be/litterature/evolution-of-replacement-therapy-for-von-willebrand-disease-from-plasma-fraction-to-recombinant-von-willebrand-factor/ 2020-06-05T13:46:53+01:00 https://www.caf-dcf.be/fr/litterature/evolution-of-replacement-therapy-for-von-willebrand-disease-from-plasma-fraction-to-recombinant-von-willebrand-factor/ 2020-06-05T13:46:40+01:00 https://www.caf-dcf.be/litterature/guidelines-for-the-prophylaxis-of-haemophilia-a-and-b-new-horizons-and-ambitions/ 2020-06-05T13:44:59+01:00 https://www.caf-dcf.be/fr/litterature/guidelines-for-the-prophylaxis-of-haemophilia-a-and-b-new-horizons-and-ambitions/ 2020-06-05T13:43:43+01:00 https://www.caf-dcf.be/litterature/differentiation-of-patients-with-symptomatic-low-von-willebrand-factor-from-those-with-asymptomatic-low-von-willebrand-factor/ 2020-06-05T13:42:11+01:00 https://www.caf-dcf.be/fr/litterature/differentiation-of-patients-with-symptomatic-low-von-willebrand-factor-from-those-with-asymptomatic-low-von-willebrand-factor/ 2020-06-05T13:41:41+01:00 https://www.caf-dcf.be/litterature/show-me-the-evidence-effectiveness-of-low-dose-prophylaxis/ 2020-06-05T13:39:57+01:00 https://www.caf-dcf.be/fr/litterature/show-me-the-evidence-effectiveness-of-low-dose-prophylaxis/ 2020-06-05T13:39:42+01:00 https://www.caf-dcf.be/litterature/detection-of-alpha-1-antitrypsin-deficiency-the-past-present-and-future/ 2020-06-05T13:33:57+01:00 https://www.caf-dcf.be/fr/litterature/detection-of-alpha-1-antitrypsin-deficiency-the-past-present-and-future/ 2020-06-05T13:33:43+01:00 https://www.caf-dcf.be/litterature/alpha-1-antitrypsin-deficiency-have-we-got-the-right-proteinase/ 2020-06-05T13:31:20+01:00 https://www.caf-dcf.be/fr/litterature/alpha-1-antitrypsin-deficiency-have-we-got-the-right-proteinase/ 2020-06-05T13:31:01+01:00 https://www.caf-dcf.be/litterature/origin-and-nature-of-the-neutralizing-immune-response-against-therapeutic-factor-viii/ 2020-06-05T13:29:27+01:00 https://www.caf-dcf.be/fr/litterature/origin-and-nature-of-the-neutralizing-immune-response-against-therapeutic-factor-viii/ 2020-06-05T13:29:03+01:00 https://www.caf-dcf.be/litterature/evaluation-of-coagulation-factor-activity-and-sterility-of-thawed-fresh-frozen-plasma-during-storage-up-to-5-days-at-4-degrees-c/ 2020-06-05T13:27:24+01:00 https://www.caf-dcf.be/fr/litterature/evaluation-of-coagulation-factor-activity-and-sterility-of-thawed-fresh-frozen-plasma-during-storage-up-to-5-days-at-4-degrees-c/ 2020-06-05T13:27:09+01:00 https://www.caf-dcf.be/litterature/factor-viii-activity-and-bleeding-risk-during-prophylaxis-for-severe-hemophilia-a-a-population-pharmacokinetic-model/ 2020-06-05T13:23:52+01:00 https://www.caf-dcf.be/fr/litterature/factor-viii-activity-and-bleeding-risk-during-prophylaxis-for-severe-hemophilia-a-a-population-pharmacokinetic-model/ 2020-06-05T13:23:37+01:00 https://www.caf-dcf.be/litterature/international-recommendations-on-the-diagnosis-and-treatment-of-acquired-hemophilia-a/ 2020-06-05T13:21:45+01:00 https://www.caf-dcf.be/fr/litterature/international-recommendations-on-the-diagnosis-and-treatment-of-acquired-hemophilia-a/ 2020-06-05T13:21:19+01:00 https://www.caf-dcf.be/litterature/antibody-mediated-complement-activation-in-pathology-and-protection/ 2020-06-05T13:18:43+01:00 https://www.caf-dcf.be/fr/litterature/antibody-mediated-complement-activation-in-pathology-and-protection/ 2020-06-05T13:18:23+01:00 https://www.caf-dcf.be/litterature/effect-of-intravenous-immunoglobulin-g-therapy-on-natural-killer-cell-function-related-to-fc-gamma-receptor-gene-expression/ 2020-06-05T13:15:01+01:00 https://www.caf-dcf.be/fr/litterature/effect-of-intravenous-immunoglobulin-g-therapy-on-natural-killer-cell-function-related-to-fc-gamma-receptor-gene-expression/ 2020-06-05T13:05:00+01:00 https://www.caf-dcf.be/litterature/how-we-manage-haemostasis-during-sepsis/ 2020-06-05T13:03:22+01:00 https://www.caf-dcf.be/fr/litterature/how-we-manage-haemostasis-during-sepsis/ 2020-06-05T13:02:58+01:00 https://www.caf-dcf.be/litterature/trials-and-tribulations-of-viscoelastic-based-determination-of-fibrinogen-concentration/ 2020-06-05T13:01:14+01:00 https://www.caf-dcf.be/fr/litterature/trials-and-tribulations-of-viscoelastic-based-determination-of-fibrinogen-concentration/ 2020-06-05T13:00:46+01:00 https://www.caf-dcf.be/litterature/more-is-not-always-better-effects-of-cell-salvage-in-cardiac-surgery-on-postoperative-fibrinogen-concentrations/ 2020-06-05T12:57:46+01:00 https://www.caf-dcf.be/fr/litterature/more-is-not-always-better-effects-of-cell-salvage-in-cardiac-surgery-on-postoperative-fibrinogen-concentrations/ 2020-06-05T12:56:43+01:00 https://www.caf-dcf.be/litterature/the-gut-microbiome-and-thromboembolism/ 2020-06-05T12:55:01+01:00 https://www.caf-dcf.be/fr/litterature/the-gut-microbiome-and-thromboembolism/ 2020-06-05T12:54:47+01:00 https://www.caf-dcf.be/litterature/comparison-of-two-different-fibrinogen-concentrates-in-an-in-vitro-model-of-dilutional-coagulopathy/ 2020-06-05T12:52:04+01:00 https://www.caf-dcf.be/fr/litterature/comparison-of-two-different-fibrinogen-concentrates-in-an-in-vitro-model-of-dilutional-coagulopathy/ 2020-06-05T12:51:26+01:00 https://www.caf-dcf.be/fr/litterature/a-molecular-revolution-in-the-treatment-of-hemophilia/ 2020-05-28T13:03:21+01:00 https://www.caf-dcf.be/litterature/a-molecular-revolution-in-the-treatment-of-hemophilia/ 2020-05-28T13:03:21+01:00 https://www.caf-dcf.be/litterature/turoctocog-alfa-pegol-provides-effective-management-for-major-and-minor-surgical-procedures-in-patients-across-all-age-groups-with-severe-haemophilia-a-full-data-set-from-the-pathfinder-3-and-5-phase/ 2020-05-28T13:00:46+01:00 https://www.caf-dcf.be/fr/litterature/turoctocog-alfa-pegol-provides-effective-management-for-major-and-minor-surgical-procedures-in-patients-across-all-age-groups-with-severe-haemophilia-a-full-data-set-from-the-pathfinder-3-and-5-phase/ 2020-05-28T13:00:45+01:00 https://www.caf-dcf.be/fr/litterature/guidance-on-the-diagnosis-and-management-of-platelet-type-von-willebrand-disease-a-communication-from-the-platelet-physiology-subcommittee-of-the-isth/ 2020-05-28T12:58:32+01:00 https://www.caf-dcf.be/litterature/guidance-on-the-diagnosis-and-management-of-platelet-type-von-willebrand-disease-a-communication-from-the-platelet-physiology-subcommittee-of-the-isth/ 2020-05-28T12:58:32+01:00 https://www.caf-dcf.be/fr/litterature/long-term-analysis-of-the-benefit-of-prophylaxis-for-adult-patients-with-severe-or-moderate-haemophilia-a/ 2020-05-28T12:56:47+01:00 https://www.caf-dcf.be/litterature/long-term-analysis-of-the-benefit-of-prophylaxis-for-adult-patients-with-severe-or-moderate-haemophilia-a/ 2020-05-28T12:56:47+01:00 https://www.caf-dcf.be/fr/litterature/factor-viii-and-ix-assays-for-post-infusion-monitoring-in-hemophilia-patients-guidelines-from-the-french-bimho-group-gfht/ 2020-05-28T12:53:54+01:00 https://www.caf-dcf.be/litterature/factor-viii-and-ix-assays-for-post-infusion-monitoring-in-hemophilia-patients-guidelines-from-the-french-bimho-group-gfht/ 2020-05-28T12:53:54+01:00 https://www.caf-dcf.be/fr/litterature/alpha-1-antitrypsin-deficiency-and-pregnancy/ 2020-05-28T12:51:26+01:00 https://www.caf-dcf.be/litterature/alpha-1-antitrypsin-deficiency-and-pregnancy/ 2020-05-28T12:51:26+01:00 https://www.caf-dcf.be/fr/litterature/advances-in-managing-rare-acquired-bleeding-disorders/ 2020-05-28T12:49:36+01:00 https://www.caf-dcf.be/litterature/advances-in-managing-rare-acquired-bleeding-disorders/ 2020-05-28T12:49:36+01:00 https://www.caf-dcf.be/fr/litterature/real-life-population-pharmacokinetics-modelling-of-eight-factors-viii-in-patients-with-severe-haemophilia-a-is-it-always-relevant-to-switch-to-an-extended-half-life/ 2020-05-28T12:45:20+01:00 https://www.caf-dcf.be/litterature/real-life-population-pharmacokinetics-modelling-of-eight-factors-viii-in-patients-with-severe-haemophilia-a-is-it-always-relevant-to-switch-to-an-extended-half-life/ 2020-05-28T12:45:20+01:00 https://www.caf-dcf.be/fr/litterature/convalescent-plasma-therapeutic-hope-or-hopeless-strategy-in-the-sars-cov-2-pandemic/ 2020-05-28T12:36:14+01:00 https://www.caf-dcf.be/litterature/convalescent-plasma-therapeutic-hope-or-hopeless-strategy-in-the-sars-cov-2-pandemic/ 2020-05-28T12:36:14+01:00 https://www.caf-dcf.be/fr/litterature/long-term-coexistence-of-sars-cov-2-with-antibody-response-in-covid-19-patients/ 2020-05-28T12:33:40+01:00 https://www.caf-dcf.be/litterature/long-term-coexistence-of-sars-cov-2-with-antibody-response-in-covid-19-patients/ 2020-05-28T12:33:40+01:00 https://www.caf-dcf.be/fr/litterature/many-faces-of-the-anti-covid-immune-response/ 2020-05-28T12:31:50+01:00 https://www.caf-dcf.be/litterature/many-faces-of-the-anti-covid-immune-response/ 2020-05-28T12:31:50+01:00 https://www.caf-dcf.be/fr/litterature/longitudinal-change-of-sars-cov2-antibodies-in-patients-with-covid-19/ 2020-05-28T12:27:36+01:00 https://www.caf-dcf.be/litterature/longitudinal-change-of-sars-cov2-antibodies-in-patients-with-covid-19/ 2020-05-28T12:27:36+01:00 https://www.caf-dcf.be/litterature/imbalanced-host-response-to-sars-cov-2-drives-development-of-covid-19/ 2020-05-28T12:25:34+01:00 https://www.caf-dcf.be/fr/litterature/imbalanced-host-response-to-sars-cov-2-drives-development-of-covid-19/ 2020-05-28T12:25:33+01:00 https://www.caf-dcf.be/fr/litterature/sars-cov-2-asymptomatic-and-symptomatic-patients-and-risk-for-transfusion-transmission/ 2020-05-28T12:21:24+01:00 https://www.caf-dcf.be/litterature/sars-cov-2-asymptomatic-and-symptomatic-patients-and-risk-for-transfusion-transmission/ 2020-05-28T12:21:24+01:00 https://www.caf-dcf.be/litterature/escape-or-fight-inhibitors-in-hemophilia-a/ 2020-04-29T11:06:06+01:00 https://www.caf-dcf.be/fr/litterature/escape-or-fight-inhibitors-in-hemophilia-a/ 2020-04-29T11:05:47+01:00 https://www.caf-dcf.be/litterature/comparative-assessment-of-von-willebrand-factor-multimers-vs-activity-for-von-willebrand-disease-using-modern-contemporary-methodologies/ 2020-04-29T11:02:03+01:00 https://www.caf-dcf.be/fr/litterature/comparative-assessment-of-von-willebrand-factor-multimers-vs-activity-for-von-willebrand-disease-using-modern-contemporary-methodologies/ 2020-04-29T11:01:38+01:00 https://www.caf-dcf.be/litterature/recombinant-factor-viii-fc-fusion-protein-for-the-treatment-of-severe-haemophilia-a-final-results-from-the-aspire-extension-study/ 2020-04-29T10:55:48+01:00 https://www.caf-dcf.be/fr/litterature/recombinant-factor-viii-fc-fusion-protein-for-the-treatment-of-severe-haemophilia-a-final-results-from-the-aspire-extension-study/ 2020-04-29T10:55:29+01:00 https://www.caf-dcf.be/litterature/the-australian-experience-with-switching-to-extended-half-life-factor-viii-and-ix-concentrates-on-behalf-of-the-australian-haemophilia-centre-directors-organization/ 2020-04-29T10:52:35+01:00 https://www.caf-dcf.be/fr/litterature/the-australian-experience-with-switching-to-extended-half-life-factor-viii-and-ix-concentrates-on-behalf-of-the-australian-haemophilia-centre-directors-organization/ 2020-04-29T10:52:05+01:00 https://www.caf-dcf.be/litterature/hemophilia-a-and-von-willebrand-deficiency-therapeutic-implications/ 2020-04-29T10:47:42+01:00 https://www.caf-dcf.be/fr/litterature/hemophilia-a-and-von-willebrand-deficiency-therapeutic-implications/ 2020-04-29T10:47:24+01:00 https://www.caf-dcf.be/litterature/product-type-and-the-risk-of-inhibitor-development-in-nonsevere-haemophilia-a-patients-a-case-control-study/ 2020-04-29T10:44:44+01:00 https://www.caf-dcf.be/fr/litterature/product-type-and-the-risk-of-inhibitor-development-in-nonsevere-haemophilia-a-patients-a-case-control-study/ 2020-04-29T10:44:13+01:00 https://www.caf-dcf.be/litterature/hemophilia-management-huge-impact-of-a-tiny-difference/ 2020-04-29T10:41:35+01:00 https://www.caf-dcf.be/fr/litterature/hemophilia-management-huge-impact-of-a-tiny-difference/ 2020-04-29T10:41:07+01:00 https://www.caf-dcf.be/litterature/efficacy-and-safety-of-octanorm-cutaquig-in-adults-with-primary-immunodeficiencies-with-predominant-antibody-deficiency-a-prospective-open-label-study/ 2020-04-29T10:34:46+01:00 https://www.caf-dcf.be/fr/litterature/efficacy-and-safety-of-octanorm-cutaquig-in-adults-with-primary-immunodeficiencies-with-predominant-antibody-deficiency-a-prospective-open-label-study/ 2020-04-29T10:34:09+01:00 https://www.caf-dcf.be/litterature/preliminary-results-of-a-randomized-clinical-trial-of-intravenous-immunoglobulin-in-solid-organ-recipients-with-severe-infection-and-secondary-antibody-deficiency/ 2020-04-29T10:31:51+01:00 https://www.caf-dcf.be/fr/litterature/preliminary-results-of-a-randomized-clinical-trial-of-intravenous-immunoglobulin-in-solid-organ-recipients-with-severe-infection-and-secondary-antibody-deficiency/ 2020-04-29T10:31:29+01:00 https://www.caf-dcf.be/litterature/prophylaxis-of-hepatitis-b-virus-hbv-re-infection-in-liver-transplantation-is-the-reappearance-of-hepatitis-b-surface-antigen-hbsag-significant/ 2020-04-29T10:29:08+01:00 https://www.caf-dcf.be/fr/litterature/prophylaxis-of-hepatitis-b-virus-hbv-re-infection-in-liver-transplantation-is-the-reappearance-of-hepatitis-b-surface-antigen-hbsag-significant/ 2020-04-29T10:28:49+01:00 https://www.caf-dcf.be/litterature/chloroquine-diphosphate-in-two-different-dosages-as-adjunctive-therapy-of-hospitalized-patients-with-severe-respiratory-syndrome-in-the-context-of-coronavirus-sars-cov-2-infection-preliminary-safet/ 2020-04-29T10:26:53+01:00 https://www.caf-dcf.be/fr/litterature/chloroquine-diphosphate-in-two-different-dosages-as-adjunctive-therapy-of-hospitalized-patients-with-severe-respiratory-syndrome-in-the-context-of-coronavirus-sars-cov-2-infection-preliminary-safet/ 2020-04-29T10:26:31+01:00 https://www.caf-dcf.be/litterature/neutralizing-antibody-responses-to-sars-cov-2-in-a-covid-19-recovered-patient-cohort-and-their-implications/ 2020-04-29T10:24:04+01:00 https://www.caf-dcf.be/fr/litterature/neutralizing-antibody-responses-to-sars-cov-2-in-a-covid-19-recovered-patient-cohort-and-their-implications/ 2020-04-29T10:23:40+01:00 https://www.caf-dcf.be/litterature/structural-and-functional-basis-of-sars-cov-2-entry-by-using-human-ace2/ 2020-04-29T10:21:47+01:00 https://www.caf-dcf.be/fr/litterature/structural-and-functional-basis-of-sars-cov-2-entry-by-using-human-ace2/ 2020-04-29T10:21:29+01:00 https://www.caf-dcf.be/litterature/pharmacologic-treatments-for-coronavirus-disease-2019-covid-19-a-review/ 2020-04-29T10:19:40+01:00 https://www.caf-dcf.be/fr/litterature/pharmacologic-treatments-for-coronavirus-disease-2019-covid-19-a-review/ 2020-04-29T10:19:18+01:00 https://www.caf-dcf.be/litterature/covid-19-attacks-the-1-beta-chain-of-hemoglobin-and-captures-the-porphyrin-to-inhibit-human-heme-metabolism/ 2020-04-29T10:16:16+01:00 https://www.caf-dcf.be/fr/litterature/covid-19-attacks-the-1-beta-chain-of-hemoglobin-and-captures-the-porphyrin-to-inhibit-human-heme-metabolism/ 2020-04-29T10:15:56+01:00 https://www.caf-dcf.be/litterature/safety-considerations-with-chloroquine-hydroxychloroquine-and-azithromycin-in-the-management-of-sars-cov-2-infection/ 2020-04-29T10:13:52+01:00 https://www.caf-dcf.be/fr/litterature/safety-considerations-with-chloroquine-hydroxychloroquine-and-azithromycin-in-the-management-of-sars-cov-2-infection/ 2020-04-29T10:13:29+01:00 https://www.caf-dcf.be/litterature/effectiveness-of-convalescent-plasma-therapy-in-severe-covid-19-patients/ 2020-04-29T10:11:45+01:00 https://www.caf-dcf.be/fr/litterature/effectiveness-of-convalescent-plasma-therapy-in-severe-covid-19-patients/ 2020-04-29T10:11:28+01:00 https://www.caf-dcf.be/litterature/severe-acute-respiratory-syndrome-coronavirus-2-rna-detected-in-blood-donations/ 2020-04-29T10:07:39+01:00 https://www.caf-dcf.be/fr/litterature/severe-acute-respiratory-syndrome-coronavirus-2-rna-detected-in-blood-donations/ 2020-04-29T10:07:21+01:00 https://www.caf-dcf.be/litterature/deployment-of-convalescent-plasma-for-the-prevention-and-treatment-of-covid-19/ 2020-04-29T10:05:13+01:00 https://www.caf-dcf.be/fr/litterature/deployment-of-convalescent-plasma-for-the-prevention-and-treatment-of-covid-19/ 2020-04-29T10:04:48+01:00 https://www.caf-dcf.be/litterature/covid-19-and-the-heart/ 2020-04-29T09:58:31+01:00 https://www.caf-dcf.be/fr/litterature/covid-19-and-the-heart/ 2020-04-29T09:58:05+01:00 https://www.caf-dcf.be/fr/litterature/coronavirus-disease-2019-coronaviruses-and-blood-safety/ 2020-04-29T09:51:01+01:00 https://www.caf-dcf.be/litterature/coronavirus-disease-2019-coronaviruses-and-blood-safety/ 2020-04-29T09:50:40+01:00 https://www.caf-dcf.be/litterature/women-with-congenital-hypofibrinogenemia-afibrinogenemia-from-birth-to-death/ 2020-04-29T09:45:16+01:00 https://www.caf-dcf.be/fr/litterature/women-with-congenital-hypofibrinogenemia-afibrinogenemia-from-birth-to-death/ 2020-04-29T09:44:57+01:00 https://www.caf-dcf.be/fr/litterature/comparison-of-fresh-frozen-plasma-vs-coagulation-factor-concentrates-for-reconstitution-of-blood-an-in-vitro-experimental-study/ 2020-04-29T09:41:38+01:00 https://www.caf-dcf.be/litterature/comparison-of-fresh-frozen-plasma-vs-coagulation-factor-concentrates-for-reconstitution-of-blood-an-in-vitro-experimental-study/ 2020-04-29T09:40:39+01:00 https://www.caf-dcf.be/litterature/patients-with-hemophilia-a-and-inhibitors-prevention-and-evolving-treatment-paradigms/ 2020-04-09T12:53:49+01:00 https://www.caf-dcf.be/fr/litterature/patients-with-hemophilia-a-and-inhibitors-prevention-and-evolving-treatment-paradigms/ 2020-04-09T12:53:21+01:00 https://www.caf-dcf.be/litterature/new-patient-centric-approaches-to-the-management-of-alpha-1-antitrypsin-deficiency/ 2020-04-09T12:51:14+01:00 https://www.caf-dcf.be/fr/litterature/new-patient-centric-approaches-to-the-management-of-alpha-1-antitrypsin-deficiency/ 2020-04-09T12:50:49+01:00 https://www.caf-dcf.be/litterature/gene-therapy-1-0-in-haemophilia-effective-and-safe-but-with-many-uncertainties/ 2020-04-09T12:49:05+01:00 https://www.caf-dcf.be/fr/litterature/gene-therapy-1-0-in-haemophilia-effective-and-safe-but-with-many-uncertainties/ 2020-04-09T12:48:42+01:00 https://www.caf-dcf.be/litterature/physiological-roles-of-the-von-willebrand-factor-factor-viii-interaction/ 2020-04-09T12:47:09+01:00 https://www.caf-dcf.be/fr/litterature/physiological-roles-of-the-von-willebrand-factor-factor-viii-interaction/ 2020-04-09T12:46:47+01:00 https://www.caf-dcf.be/litterature/an-evaluation-of-the-safety-and-efficacy-of-turoctocog-alfa-for-hemophilia-a/ 2020-04-09T12:44:42+01:00 https://www.caf-dcf.be/fr/litterature/an-evaluation-of-the-safety-and-efficacy-of-turoctocog-alfa-for-hemophilia-a/ 2020-04-09T12:44:00+01:00 https://www.caf-dcf.be/litterature/prediction-of-the-haemostatic-effects-of-bypassing-therapy-using-comprehensive-coagulation-assays-in-emicizumab-prophylaxis-treated-haemophilia-a-patients-with-inhibitors/ 2020-04-09T12:42:17+01:00 https://www.caf-dcf.be/fr/litterature/prediction-of-the-haemostatic-effects-of-bypassing-therapy-using-comprehensive-coagulation-assays-in-emicizumab-prophylaxis-treated-haemophilia-a-patients-with-inhibitors/ 2020-04-09T12:41:47+01:00 https://www.caf-dcf.be/litterature/could-intravenous-immunoglobulin-collected-from-recovered-coronavirus-patients-protect-against-covid-19-and-strengthen-the-immune-system-of-new-patients/ 2020-04-09T11:21:50+01:00 https://www.caf-dcf.be/fr/litterature/could-intravenous-immunoglobulin-collected-from-recovered-coronavirus-patients-protect-against-covid-19-and-strengthen-the-immune-system-of-new-patients/ 2020-04-09T11:21:27+01:00 https://www.caf-dcf.be/litterature/observational-safety-study-of-clottafactr-fibrinogen-concentrate-real-world-data-in-mexico/ 2020-04-09T11:19:17+01:00 https://www.caf-dcf.be/fr/litterature/observational-safety-study-of-clottafactr-fibrinogen-concentrate-real-world-data-in-mexico/ 2020-04-09T11:17:04+01:00 https://www.caf-dcf.be/litterature/whole-blood-for-civilian-urban-trauma-resuscitation-historical-present-and-future-considerations/ 2020-04-09T11:14:59+01:00 https://www.caf-dcf.be/fr/litterature/whole-blood-for-civilian-urban-trauma-resuscitation-historical-present-and-future-considerations/ 2020-04-09T11:14:33+01:00 https://www.caf-dcf.be/litterature/the-effect-of-fibrinogen-concentrate-on-postoperative-blood-loss-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials/ 2020-04-09T11:12:43+01:00 https://www.caf-dcf.be/fr/litterature/the-effect-of-fibrinogen-concentrate-on-postoperative-blood-loss-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials/ 2020-04-09T11:12:08+01:00 https://www.caf-dcf.be/litterature/platelets-and-fibrinogen-emerging-complexity-in-trauma-induced-coagulopathy/ 2020-04-09T11:10:34+01:00 https://www.caf-dcf.be/fr/litterature/platelets-and-fibrinogen-emerging-complexity-in-trauma-induced-coagulopathy/ 2020-04-09T11:09:33+01:00 https://www.caf-dcf.be/litterature/fibrinogen-concentrate-use-in-routine-practice-in-an-academic-hospital-a-retrospective-study-about-the-effects-of-fibrinogen-concentrate-administration-on-biological-parameters/ 2020-04-09T11:06:17+01:00 https://www.caf-dcf.be/fr/litterature/fibrinogen-concentrate-use-in-routine-practice-in-an-academic-hospital-a-retrospective-study-about-the-effects-of-fibrinogen-concentrate-administration-on-biological-parameters/ 2020-04-09T11:05:26+01:00 https://www.caf-dcf.be/litterature/viscoelastic-haemostatic-assays-and-fibrinogen-in-paediatric-acute-traumatic-coagulopathy-a-comprehensive-review/ 2020-04-09T11:03:41+01:00 https://www.caf-dcf.be/fr/litterature/viscoelastic-haemostatic-assays-and-fibrinogen-in-paediatric-acute-traumatic-coagulopathy-a-comprehensive-review/ 2020-04-09T11:03:05+01:00 https://www.caf-dcf.be/litterature/missing-regions-within-the-molecular-architecture-of-human-fibrin-clots-structurally-resolved-by-xl-ms-and-integrative-structural-modeling/ 2020-04-09T10:49:34+01:00 https://www.caf-dcf.be/fr/litterature/missing-regions-within-the-molecular-architecture-of-human-fibrin-clots-structurally-resolved-by-xl-ms-and-integrative-structural-modeling/ 2020-04-09T10:48:34+01:00 https://www.caf-dcf.be/litterature/therapeutic-antibodies-in-hemostasis-from-the-past-to-the-future/ 2020-03-25T10:35:07+01:00 https://www.caf-dcf.be/fr/litterature/therapeutic-antibodies-in-hemostasis-from-the-past-to-the-future/ 2020-03-25T10:34:43+01:00 https://www.caf-dcf.be/litterature/advances-in-knowledge-of-inhibitor-formation-in-severe-haemophilia-a/ 2020-03-24T14:47:22+01:00 https://www.caf-dcf.be/fr/litterature/advances-in-knowledge-of-inhibitor-formation-in-severe-haemophilia-a/ 2020-03-24T14:47:10+01:00 https://www.caf-dcf.be/litterature/switching-toward-the-use-of-recombinant-factor-viii-fc-fusion-protein-study-among-30-patients-with-severe-hemophilia-a/ 2020-03-24T14:46:26+01:00 https://www.caf-dcf.be/fr/litterature/switching-toward-the-use-of-recombinant-factor-viii-fc-fusion-protein-study-among-30-patients-with-severe-hemophilia-a/ 2020-03-24T14:46:15+01:00 https://www.caf-dcf.be/litterature/multicentre-pharmacokinetic-evaluation-of-rfviii-fc-efmoroctocog-alfa-in-a-real-life-and-comparison-with-non-extended-half-life-fviii-concentrates/ 2020-03-24T14:45:37+01:00 https://www.caf-dcf.be/fr/litterature/multicentre-pharmacokinetic-evaluation-of-rfviii-fc-efmoroctocog-alfa-in-a-real-life-and-comparison-with-non-extended-half-life-fviii-concentrates/ 2020-03-24T14:45:24+01:00 https://www.caf-dcf.be/litterature/hemophilia-prophylaxis-adherence-and-bleeding-using-a-tailored-frequency-escalated-approach-the-canadian-hemophilia-primary-prophylaxis-study/ 2020-03-24T14:44:11+01:00 https://www.caf-dcf.be/fr/litterature/hemophilia-prophylaxis-adherence-and-bleeding-using-a-tailored-frequency-escalated-approach-the-canadian-hemophilia-primary-prophylaxis-study/ 2020-03-24T14:43:51+01:00 https://www.caf-dcf.be/litterature/impact-of-the-survey-of-inhibitors-in-plasma-product-exposed-toddlers-sippet-study-and-its-post-hoc-analyses-on-clinical-practice-in-the-united-states-a-survey-of-haemophilia-and-thrombosis-researc/ 2020-03-24T14:42:56+01:00 https://www.caf-dcf.be/fr/litterature/impact-of-the-survey-of-inhibitors-in-plasma-product-exposed-toddlers-sippet-study-and-its-post-hoc-analyses-on-clinical-practice-in-the-united-states-a-survey-of-haemophilia-and-thrombosis-researc/ 2020-03-24T14:42:37+01:00 https://www.caf-dcf.be/litterature/assessing-the-potential-cost-effectiveness-of-a-gene-therapy-for-the-treatment-of-hemophilia-a/ 2020-03-24T14:41:11+01:00 https://www.caf-dcf.be/fr/litterature/assessing-the-potential-cost-effectiveness-of-a-gene-therapy-for-the-treatment-of-hemophilia-a/ 2020-03-24T14:40:41+01:00 https://www.caf-dcf.be/litterature/the-year-in-coagulation-selected-highlights-from-2019/ 2020-03-24T14:39:21+01:00 https://www.caf-dcf.be/fr/litterature/the-year-in-coagulation-selected-highlights-from-2019/ 2020-03-24T14:39:00+01:00 https://www.caf-dcf.be/litterature/hepatitis-c-and-history-of-fviii-inhibitor-development-in-a-long-term-cohort-of-brazilian-patients-with-haemophilia-a/ 2020-03-24T14:37:38+01:00 https://www.caf-dcf.be/fr/litterature/hepatitis-c-and-history-of-fviii-inhibitor-development-in-a-long-term-cohort-of-brazilian-patients-with-haemophilia-a/ 2020-03-24T14:37:17+01:00 https://www.caf-dcf.be/litterature/development-of-haemophilia-treatment-in-the-eastern-part-of-germany-over-the-last-decade-in-the-kompetenznetz-hamorrhagische-diathese-ost-khdo/ 2020-03-24T14:36:04+01:00 https://www.caf-dcf.be/fr/litterature/development-of-haemophilia-treatment-in-the-eastern-part-of-germany-over-the-last-decade-in-the-kompetenznetz-hamorrhagische-diathese-ost-khdo/ 2020-03-24T14:35:46+01:00 https://www.caf-dcf.be/litterature/clinical-evidence-and-safety-profile-of-emicizumab-for-the-management-of-children-with-hemophilia-a/ 2020-03-24T14:34:16+01:00 https://www.caf-dcf.be/fr/litterature/clinical-evidence-and-safety-profile-of-emicizumab-for-the-management-of-children-with-hemophilia-a/ 2020-03-24T14:33:57+01:00 https://www.caf-dcf.be/litterature/advances-in-understanding-mechanisms-of-thrombophilic-disorders/ 2020-03-24T14:32:16+01:00 https://www.caf-dcf.be/fr/litterature/advances-in-understanding-mechanisms-of-thrombophilic-disorders/ 2020-03-24T14:31:51+01:00 https://www.caf-dcf.be/litterature/association-between-fluid-creep-and-infection-in-burned-children-a-cohort-study/ 2020-03-24T14:18:37+01:00 https://www.caf-dcf.be/fr/litterature/association-between-fluid-creep-and-infection-in-burned-children-a-cohort-study/ 2020-03-24T14:17:37+01:00 https://www.caf-dcf.be/litterature/effect-of-fibrinogen-concentrate-administration-on-early-mortality-in-traumatic-hemorrhagic-shock-a-propensity-score-analysis/ 2020-03-24T13:44:30+01:00 https://www.caf-dcf.be/fr/litterature/effect-of-fibrinogen-concentrate-administration-on-early-mortality-in-traumatic-hemorrhagic-shock-a-propensity-score-analysis/ 2020-03-24T13:43:59+01:00 https://www.caf-dcf.be/litterature/mortality-and-factors-associated-with-hemorrhage-during-pediatric-extracorporeal-membrane-oxygenation/ 2020-03-24T13:42:10+01:00 https://www.caf-dcf.be/fr/litterature/mortality-and-factors-associated-with-hemorrhage-during-pediatric-extracorporeal-membrane-oxygenation/ 2020-03-24T13:40:39+01:00 https://www.caf-dcf.be/litterature/von-willebrand-factor-and-factor-viii-in-a-healthy-brazilian-population-association-with-abo-blood-groups/ 2020-03-24T10:24:30+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-factor-and-factor-viii-in-a-healthy-brazilian-population-association-with-abo-blood-groups/ 2020-03-24T10:24:08+01:00 https://www.caf-dcf.be/fr/litterature/benefits-and-limitations-of-extended-plasma-half-life-factor-viii-products-in-hemophilia-a-2/ 2020-03-24T10:22:32+01:00 https://www.caf-dcf.be/litterature/thrombin-generation-in-plasma-of-patients-with-haemophilia-a-and-b-with-inhibitors-effects-of-bypassing-agents-and-antithrombin-reduction/ 2020-03-24T10:21:12+01:00 https://www.caf-dcf.be/fr/litterature/thrombin-generation-in-plasma-of-patients-with-haemophilia-a-and-b-with-inhibitors-effects-of-bypassing-agents-and-antithrombin-reduction/ 2020-03-24T10:20:52+01:00 https://www.caf-dcf.be/litterature/investigational-drugs-to-treat-hemophilia/ 2020-03-24T10:19:27+01:00 https://www.caf-dcf.be/fr/litterature/investigational-drugs-to-treat-hemophilia/ 2020-03-24T10:19:07+01:00 https://www.caf-dcf.be/litterature/emicizumab-in-hemophilia-a/ 2020-03-24T10:17:29+01:00 https://www.caf-dcf.be/fr/litterature/emicizumab-in-hemophilia-a/ 2020-03-24T10:17:03+01:00 https://www.caf-dcf.be/litterature/developing-bivv001-a-new-class-of-factor-viii-replacement-for-hemophilia-a-that-is-von-willebrand-factor-independent/ 2020-03-24T10:15:34+01:00 https://www.caf-dcf.be/fr/litterature/developing-bivv001-a-new-class-of-factor-viii-replacement-for-hemophilia-a-that-is-von-willebrand-factor-independent/ 2020-03-24T10:15:10+01:00 https://www.caf-dcf.be/litterature/hemophilia-therapy-the-future-has-begun/ 2020-03-24T10:13:33+01:00 https://www.caf-dcf.be/fr/litterature/hemophilia-therapy-the-future-has-begun/ 2020-03-24T10:13:14+01:00 https://www.caf-dcf.be/litterature/clinical-controversies-in-anticoagulation-monitoring-and-antithrombin-supplementation-for-ecmo/ 2020-03-24T10:11:50+01:00 https://www.caf-dcf.be/fr/litterature/clinical-controversies-in-anticoagulation-monitoring-and-antithrombin-supplementation-for-ecmo/ 2020-03-24T10:11:25+01:00 https://www.caf-dcf.be/litterature/acquired-von-willebrand-syndrome-in-pediatric-extracorporeal-membrane-oxygenation-sheared-and-cleaved-everywhere-but-what-to-do-about-it/ 2020-03-24T10:10:03+01:00 https://www.caf-dcf.be/fr/litterature/acquired-von-willebrand-syndrome-in-pediatric-extracorporeal-membrane-oxygenation-sheared-and-cleaved-everywhere-but-what-to-do-about-it/ 2020-03-24T10:09:38+01:00 https://www.caf-dcf.be/fr/litterature/re-personalization-and-stratification-of-hemophilia-care-in-an-evolving-treatment-landscape/ 2020-03-24T10:05:00+01:00 https://www.caf-dcf.be/litterature/factor-viii-perspectives-on-immunogenicity-and-tolerogenic-strategies/ 2020-03-24T10:03:37+01:00 https://www.caf-dcf.be/fr/litterature/factor-viii-perspectives-on-immunogenicity-and-tolerogenic-strategies/ 2020-03-24T10:03:13+01:00 https://www.caf-dcf.be/litterature/benefits-and-limitations-of-extended-plasma-half-life-factor-viii-products-in-hemophilia-a/ 2020-03-24T10:01:57+01:00 https://www.caf-dcf.be/fr/litterature/benefits-and-limitations-of-extended-plasma-half-life-factor-viii-products-in-hemophilia-a/ 2020-03-24T10:01:37+01:00 https://www.caf-dcf.be/litterature/tolerating-factor-viii-recent-progress/ 2020-03-24T09:59:55+01:00 https://www.caf-dcf.be/fr/litterature/tolerating-factor-viii-recent-progress/ 2020-03-24T09:59:33+01:00 https://www.caf-dcf.be/litterature/a-sticky-proposition-the-endothelial-glycocalyx-and-von-willebrand-factor/ 2020-03-24T09:57:34+01:00 https://www.caf-dcf.be/fr/litterature/a-sticky-proposition-the-endothelial-glycocalyx-and-von-willebrand-factor/ 2020-03-24T09:57:14+01:00 https://www.caf-dcf.be/litterature/acquired-hemophilia/ 2020-03-24T09:55:39+01:00 https://www.caf-dcf.be/fr/litterature/acquired-hemophilia/ 2020-03-24T09:55:15+01:00 https://www.caf-dcf.be/litterature/the-role-of-genetics-in-the-pathogenesis-and-diagnosis-of-type-1-von-willebrand-disease/ 2020-03-24T09:53:44+01:00 https://www.caf-dcf.be/fr/litterature/the-role-of-genetics-in-the-pathogenesis-and-diagnosis-of-type-1-von-willebrand-disease/ 2020-03-24T09:53:20+01:00 https://www.caf-dcf.be/litterature/in-vitro-assessment-of-von-willebrand-factor-in-cryoprecipitate-antihemophilic-factor-vwf-complex-human-and-recombinant-von-willebrand-factor/ 2020-03-24T09:51:30+01:00 https://www.caf-dcf.be/fr/litterature/in-vitro-assessment-of-von-willebrand-factor-in-cryoprecipitate-antihemophilic-factor-vwf-complex-human-and-recombinant-von-willebrand-factor/ 2020-03-24T09:51:11+01:00 https://www.caf-dcf.be/litterature/comparison-of-antithrombin-iii-products-in-pediatric-patients-receiving-extracorporeal-membrane-oxygenation/ 2020-03-24T09:48:55+01:00 https://www.caf-dcf.be/fr/litterature/comparison-of-antithrombin-iii-products-in-pediatric-patients-receiving-extracorporeal-membrane-oxygenation/ 2020-03-24T09:48:35+01:00 https://www.caf-dcf.be/litterature/the-current-understanding-of-molecular-pathogenesis-of-quantitative-von-willebrand-disease-types-1-and-3/ 2020-03-24T09:47:11+01:00 https://www.caf-dcf.be/fr/litterature/the-current-understanding-of-molecular-pathogenesis-of-quantitative-von-willebrand-disease-types-1-and-3/ 2020-03-24T09:46:47+01:00 https://www.caf-dcf.be/litterature/perioperative-safety-and-haematostatic-efficacy-of-a-new-bypassing-agent-pd-fviia-fx-byclot-in-haemophilia-patients-with-high-responding-type-inhibitors/ 2020-03-24T09:45:12+01:00 https://www.caf-dcf.be/fr/litterature/perioperative-safety-and-haematostatic-efficacy-of-a-new-bypassing-agent-pd-fviia-fx-byclot-in-haemophilia-patients-with-high-responding-type-inhibitors/ 2020-03-24T09:44:50+01:00 https://www.caf-dcf.be/litterature/therapeutic-innovations-for-hemophilia/ 2020-03-24T09:43:19+01:00 https://www.caf-dcf.be/fr/litterature/therapeutic-innovations-for-hemophilia/ 2020-03-24T09:42:59+01:00 https://www.caf-dcf.be/litterature/molecular-mechanisms-of-inhibitor-development-in-hemophilia/ 2020-03-24T09:41:28+01:00 https://www.caf-dcf.be/fr/litterature/molecular-mechanisms-of-inhibitor-development-in-hemophilia/ 2020-03-24T09:40:53+01:00 https://www.caf-dcf.be/litterature/the-cost-of-hemophilia-treatment-the-importance-of-minimizing-it-without-detriment-to-its-quality/ 2020-03-24T09:39:19+01:00 https://www.caf-dcf.be/fr/litterature/the-cost-of-hemophilia-treatment-the-importance-of-minimizing-it-without-detriment-to-its-quality/ 2020-03-24T09:38:56+01:00 https://www.caf-dcf.be/litterature/von-willebrand-disease-from-in-vivo-to-in-vitro-disease-models/ 2020-03-24T09:37:19+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-disease-from-in-vivo-to-in-vitro-disease-models/ 2020-03-24T09:36:55+01:00 https://www.caf-dcf.be/fr/litterature/clinical-approach-to-manage-gastrointestinal-bleeding-with-a-left-ventricular-assist-device-lvad/ 2020-03-24T09:34:57+01:00 https://www.caf-dcf.be/litterature/multiyear-follow-up-of-aav5-hfviii-sq-gene-therapy-for-hemophilia-a/ 2020-03-24T09:33:17+01:00 https://www.caf-dcf.be/fr/litterature/multiyear-follow-up-of-aav5-hfviii-sq-gene-therapy-for-hemophilia-a/ 2020-03-24T09:32:48+01:00 https://www.caf-dcf.be/litterature/cost-effectiveness-and-budget-impact-of-emicizumab-prophylaxis-in-haemophilia-a-patients-with-inhibitors/ 2020-03-23T15:32:12+01:00 https://www.caf-dcf.be/fr/litterature/cost-effectiveness-and-budget-impact-of-emicizumab-prophylaxis-in-haemophilia-a-patients-with-inhibitors/ 2020-03-23T15:31:34+01:00 https://www.caf-dcf.be/fr/litterature/genetic-background-of-von-willebrand-disease-history-current-state-and-future-perspectives/ 2020-03-23T15:28:19+01:00 https://www.caf-dcf.be/litterature/activated-prothrombin-complex-concentrate-feiba-in-acquired-haemophilia-a-a-large-multicentre-italian-study-the-fair-registry/ 2020-03-23T15:26:05+01:00 https://www.caf-dcf.be/fr/litterature/activated-prothrombin-complex-concentrate-feiba-in-acquired-haemophilia-a-a-large-multicentre-italian-study-the-fair-registry/ 2020-03-23T15:25:36+01:00 https://www.caf-dcf.be/litterature/vonicog-alfa-for-the-management-of-von-willebrand-disease-a-comprehensive-review-and-single-center-experience/ 2020-03-23T15:21:39+01:00 https://www.caf-dcf.be/fr/litterature/vonicog-alfa-for-the-management-of-von-willebrand-disease-a-comprehensive-review-and-single-center-experience/ 2020-03-23T15:20:56+01:00 https://www.caf-dcf.be/litterature/assessing-prophylactic-use-and-clinical-outcomes-in-hemophilia-a-patients-treated-with-rviii-singlechain-and-other-common-rfviii-products-in-germany/ 2020-03-23T15:18:08+01:00 https://www.caf-dcf.be/fr/litterature/assessing-prophylactic-use-and-clinical-outcomes-in-hemophilia-a-patients-treated-with-rviii-singlechain-and-other-common-rfviii-products-in-germany/ 2020-03-23T15:17:42+01:00 https://www.caf-dcf.be/litterature/factor-viii-the-protein-cloning-its-gene-synthetic-factor-and-now-35-years-later-gene-therapy-what-happened-in-between/ 2020-03-23T15:15:49+01:00 https://www.caf-dcf.be/fr/litterature/factor-viii-the-protein-cloning-its-gene-synthetic-factor-and-now-35-years-later-gene-therapy-what-happened-in-between/ 2020-03-23T15:15:21+01:00 https://www.caf-dcf.be/litterature/factor-viii-replacement-is-still-the-standard-of-care-in-haemophilia-a/ 2020-03-23T14:57:42+01:00 https://www.caf-dcf.be/fr/litterature/factor-viii-replacement-is-still-the-standard-of-care-in-haemophilia-a/ 2020-03-23T14:57:14+01:00 https://www.caf-dcf.be/litterature/intravenous-immunoglobulin-for-preventing-infection-in-preterm-and-or-low-birth-weight-infants/ 2020-03-23T14:48:05+01:00 https://www.caf-dcf.be/fr/litterature/intravenous-immunoglobulin-for-preventing-infection-in-preterm-and-or-low-birth-weight-infants/ 2020-03-23T14:47:35+01:00 https://www.caf-dcf.be/litterature/immune-globulin-subcutaneous-human-20-solution-xembifyr-a-new-high-concentration-immunoglobulin-product-for-subcutaneous-administration/ 2020-03-23T14:43:31+01:00 https://www.caf-dcf.be/fr/litterature/immune-globulin-subcutaneous-human-20-solution-xembifyr-a-new-high-concentration-immunoglobulin-product-for-subcutaneous-administration/ 2020-03-23T14:42:58+01:00 https://www.caf-dcf.be/litterature/progress-in-hematopoietic-stem-cell-transplantation-for-cidp/ 2020-03-23T14:25:34+01:00 https://www.caf-dcf.be/fr/litterature/progress-in-hematopoietic-stem-cell-transplantation-for-cidp/ 2020-03-23T14:23:33+01:00 https://www.caf-dcf.be/fr/litterature/current-treatment-practice-of-guillain-barre-syndrome-2/ 2020-03-23T14:20:19+01:00 https://www.caf-dcf.be/litterature/current-treatment-practice-of-guillain-barre-syndrome-2/ 2020-03-23T14:19:47+01:00 https://www.caf-dcf.be/litterature/differences-in-patient-demographics-and-healthcare-costs-of-patients-with-pidd-receiving-intravenous-or-subcutaneous-immunoglobulin-therapies-in-the-united-states/ 2020-03-23T14:16:59+01:00 https://www.caf-dcf.be/fr/litterature/differences-in-patient-demographics-and-healthcare-costs-of-patients-with-pidd-receiving-intravenous-or-subcutaneous-immunoglobulin-therapies-in-the-united-states/ 2020-03-23T14:16:06+01:00 https://www.caf-dcf.be/litterature/fibrinogen-supplementation-and-its-indications/ 2020-03-20T16:14:26+01:00 https://www.caf-dcf.be/fr/litterature/fibrinogen-supplementation-and-its-indications/ 2020-03-20T16:13:59+01:00 https://www.caf-dcf.be/litterature/obstetrical-and-postpartum-complications-in-women-with-hereditary-fibrinogen-disorders-a-systematic-literature-review/ 2020-03-20T16:10:26+01:00 https://www.caf-dcf.be/fr/litterature/obstetrical-and-postpartum-complications-in-women-with-hereditary-fibrinogen-disorders-a-systematic-literature-review/ 2020-03-20T16:09:48+01:00 https://www.caf-dcf.be/litterature/lactate-and-fibrinogen-as-good-predictors-of-massive-transfusion-in-postpartum-hemorrhage/ 2020-03-20T16:07:20+01:00 https://www.caf-dcf.be/fr/litterature/lactate-and-fibrinogen-as-good-predictors-of-massive-transfusion-in-postpartum-hemorrhage/ 2020-03-20T16:06:53+01:00 https://www.caf-dcf.be/litterature/thromboelastography-targeted-management-of-severe-coagulopathy-and-off-label-use-of-four-factor-prothrombin-complex-concentrate-in-an-infant-with-massive-bleeding/ 2020-03-20T16:00:27+01:00 https://www.caf-dcf.be/fr/litterature/thromboelastography-targeted-management-of-severe-coagulopathy-and-off-label-use-of-four-factor-prothrombin-complex-concentrate-in-an-infant-with-massive-bleeding/ 2020-03-20T15:55:02+01:00 https://www.caf-dcf.be/litterature/clotting-factors-clinical-biochemistry-and-their-roles-as-plasma-enzymes/ 2020-03-20T15:45:00+01:00 https://www.caf-dcf.be/fr/litterature/clotting-factors-clinical-biochemistry-and-their-roles-as-plasma-enzymes/ 2020-03-20T15:44:31+01:00 https://www.caf-dcf.be/litterature/effects-of-post-translational-modifications-of-fibrinogen-on-clot-formation-clot-structure-and-fibrinolysis-a-systematic-review/ 2020-03-20T15:41:43+01:00 https://www.caf-dcf.be/fr/litterature/effects-of-post-translational-modifications-of-fibrinogen-on-clot-formation-clot-structure-and-fibrinolysis-a-systematic-review/ 2020-03-20T15:41:02+01:00 https://www.caf-dcf.be/litterature/early-administration-of-fibrinogen-concentrate-is-associated-with-improved-survival-among-severe-trauma-patients-a-single-centre-propensity-score-matched-analysis/ 2020-03-20T15:35:29+01:00 https://www.caf-dcf.be/fr/litterature/early-administration-of-fibrinogen-concentrate-is-associated-with-improved-survival-among-severe-trauma-patients-a-single-centre-propensity-score-matched-analysis/ 2020-03-20T15:35:03+01:00 https://www.caf-dcf.be/litterature/fibrinogen-concentrate-for-treatment-of-bleeding-and-surgical-prophylaxis-in-congenital-fibrinogen-deficiency-patients/ 2020-03-20T15:33:00+01:00 https://www.caf-dcf.be/fr/litterature/fibrinogen-concentrate-for-treatment-of-bleeding-and-surgical-prophylaxis-in-congenital-fibrinogen-deficiency-patients/ 2020-03-20T15:32:29+01:00 https://www.caf-dcf.be/litterature/perioperative-fluid-management-for-major-elective-surgery/ 2020-03-20T15:28:02+01:00 https://www.caf-dcf.be/fr/litterature/perioperative-fluid-management-for-major-elective-surgery/ 2020-03-20T15:27:24+01:00 https://www.caf-dcf.be/litterature/the-prophylactic-use-of-fibrinogen-concentrate-in-high-risk-cardiac-surgery/ 2020-03-20T15:25:01+01:00 https://www.caf-dcf.be/fr/litterature/the-prophylactic-use-of-fibrinogen-concentrate-in-high-risk-cardiac-surgery/ 2020-03-20T15:24:48+01:00 https://www.caf-dcf.be/litterature/thromboelastometry-assessment-of-the-effects-of-fibrinogen-activated-prothrombin-complex-concentrate-and-tranexamic-acid-on-clot-formation-and-fibrinolysis-in-a-model-of-trauma-induced-coagulopathy/ 2020-03-20T15:20:01+01:00 https://www.caf-dcf.be/fr/litterature/thromboelastometry-assessment-of-the-effects-of-fibrinogen-activated-prothrombin-complex-concentrate-and-tranexamic-acid-on-clot-formation-and-fibrinolysis-in-a-model-of-trauma-induced-coagulopathy/ 2020-03-20T15:19:23+01:00 https://www.caf-dcf.be/litterature/optimization-of-von-willebrand-factor-multimer-analysis-in-vertical-mini-gel-electrophoresis-systems-a-rapid-procedure/ 2020-03-20T14:56:13+01:00 https://www.caf-dcf.be/litterature/inhibitors-a-need-for-eradication/ 2020-03-20T14:54:44+01:00 https://www.caf-dcf.be/litterature/gastrointestinal-angiodysplasia-in-two-patients-with-type-3-von-willebrand-disease/ 2020-03-20T14:53:32+01:00 https://www.caf-dcf.be/litterature/von-willebrand-factor-sialylation-a-critical-regulator-of-biological-function/ 2020-03-20T12:06:00+01:00 https://www.caf-dcf.be/litterature/replacement-therapy-in-patients-with-von-willebrand-disease-indications-and-monitoring/ 2020-03-20T12:03:39+01:00 https://www.caf-dcf.be/litterature/retrospective-correlation-analysis-of-plasma-immunoglobulin-g-and-clinical-performance-in-cidp/ 2020-03-20T12:01:41+01:00 https://www.caf-dcf.be/litterature/management-of-bleeding-and-invasive-procedures-in-haemophilia-a-patients-with-inhibitor-treated-with-emicizumab-hemlibra-proposals-from-the-french-network-on-inherited-bleeding-disorders-mhe/ 2020-03-20T11:59:37+01:00 https://www.caf-dcf.be/litterature/how-we-make-an-accurate-diagnosis-of-von-willebrand-disease/ 2020-03-20T11:58:24+01:00 https://www.caf-dcf.be/litterature/pre‑procedural-abnormal-function-of-von-willebrand-factor-is-predictive-of-bleeding-after-surgical-but-not-transcatheter-aortic-valve-replacement/ 2020-03-20T11:57:07+01:00 https://www.caf-dcf.be/litterature/bmi-is-an-important-determinant-of-vwf-and-fviii-levels-and-bleeding-phenotype-in-patients-with-von-willebrand-disease-november-2019/ 2020-03-20T11:55:15+01:00 https://www.caf-dcf.be/litterature/the-changing-face-of-immune-tolerance-induction-in-haemophilia-a-with-the-advent-of-emicizumab/ 2020-03-20T11:54:42+01:00 https://www.caf-dcf.be/litterature/haemostasis-in-oral-surgical-procedures-involving-patients-with-a-ventricular-assist-device/ 2020-03-20T11:44:59+01:00 https://www.caf-dcf.be/litterature/the-evolution-of-factor-viia-in-the-treatment-of-bleeding-in-haemophilia-with-inhibitors/ 2020-03-20T11:43:19+01:00 https://www.caf-dcf.be/litterature/von-willebrand-factor-alloantibodies-in-type-3-von-willebrand-disease/ 2020-03-20T11:36:31+01:00 https://www.caf-dcf.be/litterature/new-hemostatic-agents-perioperative-anesthetic-considerations/ 2020-03-20T11:34:47+01:00 https://www.caf-dcf.be/litterature/peri-procedural-hemostasis-disorders-in-surgical-and-transcatheter-aortic-valve-implantation/ 2020-03-20T11:11:29+01:00 https://www.caf-dcf.be/litterature/comparison-of-ivig-5-versus-10-in-hematological-patients-with-a-secondary-immunodeficiency-disorder/ 2020-03-20T10:57:30+01:00 https://www.caf-dcf.be/litterature/deaths-associated-with-emicizumab-in-patients-with-hemophilia-a/ 2020-03-20T10:53:44+01:00 https://www.caf-dcf.be/fr/litterature/accuracy-of-a-rapid-diagnostic-test-for-the-presence-of-direct-oral-factor-xa-or-thrombin-inhibitors-in-urine-a-multicenter-trial/ 2020-03-20T10:49:43+01:00 https://www.caf-dcf.be/litterature/acquired-von-willebrand-syndrome-in-pediatric-extracorporeal-membrane-oxygenation-patients-a-single-institutions-experience/ 2020-03-20T10:14:57+01:00 https://www.caf-dcf.be/litterature/__trashed-2/ 2020-03-20T10:07:41+01:00 https://www.caf-dcf.be/litterature/accuracy-of-a-rapid-diagnostic-test-for-the-presence-of-direct-oral-factor-xa-or-thrombin-inhibitors-in-urine-a-multicenter-trial/ 2020-03-20T09:49:39+01:00 https://www.caf-dcf.be/litterature/new-therapies-for-von-willebrand-disease/ 2020-03-20T09:41:46+01:00 https://www.caf-dcf.be/litterature/current-treatment-practice-of-guillain-barre-syndrome/ 2020-03-19T16:39:54+01:00 https://www.caf-dcf.be/fr/litterature/current-treatment-practice-of-guillain-barre-syndrome/ 2020-03-19T16:36:26+01:00 https://www.caf-dcf.be/fr/litterature/randomized-controlled-crossover-study-of-ivig-for-demyelinating-polyneuropathy-and-diabetes/ 2020-03-19T16:24:19+01:00 https://www.caf-dcf.be/litterature/randomized-controlled-crossover-study-of-ivig-for-demyelinating-polyneuropathy-and-diabetes/ 2020-03-19T16:23:52+01:00 https://www.caf-dcf.be/fr/litterature/retrospective-correlation-analysis-of-plasma-immunoglobulin-g-and-clinical-performance-in-cidp/ 2020-03-17T15:16:11+01:00 https://www.caf-dcf.be/fr/litterature/acquired-von-willebrand-syndrome-in-patients-on-long-term-left-ventricular-assist-device-support-results-of-a-belgian-center/ 2020-03-17T14:57:39+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-factor-alloantibodies-in-type-3-von-willebrand-disease/ 2020-03-17T14:54:40+01:00 https://www.caf-dcf.be/fr/litterature/inhibitors-a-need-for-eradication/ 2020-03-17T14:51:59+01:00 https://www.caf-dcf.be/fr/litterature/the-evolution-of-factor-viia-in-the-treatment-of-bleeding-in-haemophilia-with-inhibitors/ 2020-03-17T14:50:24+01:00 https://www.caf-dcf.be/fr/litterature/new-therapies-for-von-willebrand-disease/ 2020-03-17T14:48:24+01:00 https://www.caf-dcf.be/fr/litterature/von-willebrand-factor-sialylation-a-critical-regulator-of-biological-function/ 2020-03-17T14:44:26+01:00 https://www.caf-dcf.be/fr/litterature/optimization-of-von-willebrand-factor-multimer-analysis-in-vertical-mini-gel-electrophoresis-systems-a-rapid-procedure/ 2020-03-17T14:41:35+01:00 https://www.caf-dcf.be/fr/litterature/management-of-bleeding-and-invasive-procedures-in-haemophilia-a-patients-with-inhibitor-treated-with-emicizumab-hemlibra-proposals-from-the-french-network-on-inherited-bleeding-disorders-mhe/ 2020-03-17T14:39:03+01:00 https://www.caf-dcf.be/fr/litterature/acquired-von-willebrand-syndrome-in-pediatric-extracorporeal-membrane-oxygenation-patients-a-single-institutions-experience/ 2020-03-17T14:36:27+01:00 https://www.caf-dcf.be/fr/litterature/replacement-therapy-in-patients-with-von-willebrand-disease-indications-and-monitoring/ 2020-03-17T14:33:13+01:00 https://www.caf-dcf.be/fr/litterature/gastrointestinal-angiodysplasia-in-two-patients-with-type-3-von-willebrand-disease/ 2020-03-17T14:17:14+01:00 https://www.caf-dcf.be/fr/litterature/haemostasis-in-oral-surgical-procedures-involving-patients-with-a-ventricular-assist-device/ 2020-03-17T14:14:39+01:00 https://www.caf-dcf.be/fr/litterature/pre‑procedural-abnormal-function-of-von-willebrand-factor-is-predictive-of-bleeding-after-surgical-but-not-transcatheter-aortic-valve-replacement/ 2020-03-17T14:12:35+01:00 https://www.caf-dcf.be/fr/litterature/how-we-make-an-accurate-diagnosis-of-von-willebrand-disease/ 2020-03-17T14:09:02+01:00 https://www.caf-dcf.be/fr/litterature/deaths-associated-with-emicizumab-in-patients-with-hemophilia-a/ 2020-03-17T14:05:42+01:00 https://www.caf-dcf.be/fr/litterature/comparison-of-ivig-5-versus-10-in-hematological-patients-with-a-secondary-immunodeficiency-disorder/ 2020-03-17T11:41:25+01:00 https://www.caf-dcf.be/fr/litterature/factors-associated-with-headache-in-intravenous-immunoglobulin-treatment-for-neurological-diseases/ 2020-03-17T11:22:00+01:00 https://www.caf-dcf.be/fr/litterature/immunosuppressive-and-immunomodulatory-therapies-for-neuromuscular-diseases-part-i-traditional-agents/ 2020-03-13T15:42:10+01:00 https://www.caf-dcf.be/fr/litterature/peri-procedural-hemostasis-disorders-in-surgical-and-transcatheter-aortic-valve-implantation/ 2020-03-13T15:39:46+01:00 https://www.caf-dcf.be/fr/litterature/new-hemostatic-agents-perioperative-anesthetic-considerations/ 2020-03-13T15:36:09+01:00 https://www.caf-dcf.be/fr/litterature/bmi-is-an-important-determinant-of-vwf-and-fviii-levels-and-bleeding-phenotype-in-patients-with-von-willebrand-disease/ 2020-03-12T16:13:30+01:00 https://www.caf-dcf.be/litterature/benefits-and-limitations-of-extended-plasma-half-life-factor-viii-products-in-hemophilia-a-2/ 2020-02-24T10:21:37+01:00 https://www.caf-dcf.be/fr/litterature/the-changing-face-of-immune-tolerance-induction-in-haemophilia-a-with-the-advent-of-emicizumab/ 2020-02-21T13:03:19+01:00 https://www.caf-dcf.be/litterature/re-personalization-and-stratification-of-hemophilia-care-in-an-evolving-treatment-landscape/ 2020-01-24T10:04:02+01:00 https://www.caf-dcf.be/litterature/clinical-approach-to-manage-gastrointestinal-bleeding-with-a-left-ventricular-assist-device-lvad/ 2020-01-24T09:33:50+01:00 https://www.caf-dcf.be/litterature/genetic-background-of-von-willebrand-disease-history-current-state-and-future-perspectives/ 2020-01-23T15:26:41+01:00 https://www.caf-dcf.be/litterature/factors-associated-with-headache-in-intravenous-immunoglobulin-treatment-for-neurological-diseases/ 2019-12-12T14:45:38+01:00 https://www.caf-dcf.be/litterature/acquired-von-willebrand-syndrome-in-patients-on-long-term-left-ventricular-assist-device-support-results-of-a-belgian-center/ 2019-11-17T14:54:46+01:00